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ABSTRACT 
 
Placement of sperm deep in the equine uterine horn allows fewer sperm to be 
inseminated while maintaining acceptable fertility, and has been promoted for use in 
circumstances when fertility would be expected to be low if standard insemination were 
used (e.g. semen from a subfertile stallion, or frozen-thawed semen). Two main deep-
horn insemination techniques, transrectally guided (TRG) and hysteroscopic (HYS) 
insemination, have been developed for this purpose; however, there is some controversy 
regarding their comparative efficacy. This study was conducted to compare pregnancy 
rates when mares were inseminated by TRG or HYS, utilizing sperm numbers 
approaching and under the threshold for maximal fertility, resulting in reduced fertility. 
Pregnancy rates were not different between HYS and TRG techniques when 1 x 106 or 
0.5 x 106 sperm were inseminated. Combined pregnancy rates for the two techniques 
were also not different. Pregnancy rates using a subthreshold number of sperm were not 
significantly affected by a deep-horn insemination technique. 
Dilution of semen to less than 20 x 106 sperm/mL has been reported to decrease 
semen quality in multiple species, a phenomenon known as the semen “dilution effect.” 
The sperm concentrations utilized in Experiment 1 were 5 and 2.5 x 106/mL (1 and 0.5 x 
106 sperm doses, respectively). This experiment was performed to evaluate whether the 
lower pregnancy rates obtained with 0.5 x 106 sperm was due to lower quality plasma 
membrane integrity (PMI) and sperm motion characteristics (TMOT, PMOT, VCL, 
VAP, VSL, STR). Treatments evaluated included 2.5 x 106 sperm/mL with the addition 
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of 0, 7.5, and 25% seminal plasma, 30 x 106 sperm/mL, and 3:1 extender:semen. The 2.5 
x 106 sperm/mL treatments have lower initial PMI, TMOT, and PMOT, but they 
maintain their initial quality following 24 and 48 h of cool-storage. The sperm velocity 
and straightness parameters suggest that sperm swim faster but have a more circular 
pattern as seminal plasma increases to 25% at a given concentration. Based on the 
findings from this experiment, the semen “dilution effect” may not significantly alter 
stallion sperm characteristics when a commercially-available semen extender is used for 
semen dilution. 
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NOMENCLATURE 
 
 
2.5/0 2.5 x 106 Sperm/mL with 0% Seminal Plasma Added 
2.5/7.5 2.5 x 106 Sperm/mL with 7.5% Seminal Plasma Added 
2.5/25 2.5 x 106 Sperm/mL with 25% Seminal Plasma Added 
30 30 x 106 Sperm/mL 
3:1/30 Semen Diluted 3 Parts Semen to 1 Part Extender Than Diluted to 
30 x 106 Sperm/mL Prior to Analysis 
3:1SD Semen Diluted 3 Parts Semen to 1 Part Extender 
AI Artificial Insemination 
DHI Deep-Horn Insemination 
Experiment 1 Chapter II Experiment 
Experiment 2 Chapter III Experiment 
HYS Hysteroscopic Deep-Horn Insemination 
INRA-T INRA 96 (IMV, Maple Grove, MN, USA) containing 1 mg/mL 
(w:v) ticarcillin disodium and clavulanate potassium (Timentin®; 
GlaxoSmithKline, Research Triangle Park, NC, USA) 
PMI Plasma Membrane Intact 
PMS Progressively Motile Sperm 
SP Seminal Plasma 
T0 At the Time of Semen Collection 
T24 Following 24 Hours of Cooled Storage at 7-8°C 
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T48 Following 48 Hours of Cooled Storage at 7-8°C 
T-End Following Insemination of All Mares for the Day 
TRG Transrectally guided Deep-Horn Insemination 
UBI Uterine Body Insemination 
UGIUI Ultrasound-Guided Intrauterine Injection  
V:V Volume to Volume Ratio 
WBFSH  World Breeding Federation of Sport Horses 
W:V Weight to Volume 
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 CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW* 
 
I.1. Deep-Horn Insemination 
Artificial insemination (AI) has become a common technique in the equine 
industry with most breed registries permitting its use. Traditional AI in the mare 
typically involves depositing a minimum of 250 to 500 x 106 progressively motile sperm 
(PMS) in the uterine body of the mare [1]. To accommodate decline in motility 
following cooling to 4-6°C for 24 h, an insemination dose of 1 x 109 PMS is commonly 
used as a cool-stored insemination dose [1]. A lower cool-stored insemination dose, such 
as the recommendation of ≥600 x 106 PMS by the World Breeding Federation of Sport 
Horses (WBFSH), has also been recommended [2]. Frozen semen doses are not as 
standardized as fresh and cool-stored doses; however, the WBFSH recommends that a 
frozen semen dose have a minimum post-thaw progressive motility of 35% and contain a 
minimum of 250 x 106 PMS [2].  
In the last 15 years, a form of AI called deep-horn insemination (DHI) has been 
reintroduced to the equine industry. Deep-horn insemination involves deposition of a 
low volume of extended semen at or near the oviductal papilla ipsilateral to the 
preovulatory follicle. In a study comparing the percentage of sperm in the oviducts of  
_____________________ 
 
*Part of this chapter is reprinted with permission from Hayden SS, Blanchard TL, Brinsko SP, Varner DD, 
Hinrichs K, Love CC. Pregnancy rates in mares inseminated with 0.5 or 1 million sperm using 
hysteroscopic or transrectally guided deep-horn insemination techniques. Theriogenology 2012;78:914-20. 
Copyright 2012 by Elsevier Publishing. 
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mares 18 h following uterine body (UBI) or DHI with 500 x 106 total sperm extended to 
a 10-mL volume, Rigby et al. [3] reported no difference in the percentage of sperm in 
the two oviducts (UBI = 0.0007%, DHI = 0.0006%). When comparing the percentage of 
recovered sperm found within the oviduct ipsilateral or contralateral to the preovulatory 
follicle, a higher percentage was found in the oviduct ipsilateral to the preovulatory 
follicle in mares inseminated with DHI (77%) versus UBI (54%). Based on these results, 
sperm deposition closer to the site of fertilization, rather than in the uterine body, may 
enhance fertility, in circumstances when sperm numbers are limited or compromised. 
Deep-horn insemination has been successfully used in conjunction with frozen-thawed 
sperm from fertile stallions [4-8], with fresh [9-14] or cool-stored [10,11,14] sperm from 
subfertile stallions, with sex-sorted sperm [15-18], and with epididymal sperm [19-21].  
Three types of DHI have been described in the mare: hysteroscopic (HYS), 
transrectally guided (TRG), and ultrasound-guided intrauterine injection (UGIUI). Deep-
horn insemination was first reported by two teams of investigators in 1998. Vazquez et 
al. [22] achieved a 30% (3/10) pregnancy rate when they placed 20 µL of semen 
containing 7 million total sperm from a known fertile stallion onto the oviductal papilla 
using a flexible endoscope with an insemination catheter passed through its biopsy 
channel (HYS). Manning et al. [23] also used a videoendoscopic-assisted insemination 
procedure, attempted to cannulate the oviductal papilla at the time of insemination. Zero 
of 11 (0%) and 2 of 9 mares (22%) became pregnant when inseminated with 10 million 
(250 µL), or 1 million (<160 µL), morphologically normal, progressively motile sperm, 
respectively. In comparison, 4 of 12 (33%) and 2 of 12 mares (17%) of mares were 
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pregnant following insemination into the uterine body with 100 x 106 or 10 x 106 
morphologically normal, progressively motile sperm, respectively.  
Subsequent to the first two HYS studies, Buchanan et al. [15] introduced the 
transrectally guided deep-horn insemination (TRG) technique. These workers passed 
either a flexible plastic AI pipette (1-mL dose volumes) or a disposable implant gun 
(0.2-mL dose volumes) to the tip of the uterine horn ipsilateral to the preovulatory 
follicle utilizing transrectal manipulation, confirmed the pipette or gun location with 
transrectal ultrasonography, and then deposited semen at the tip of the uterine horn. They 
reported no difference in pregnancy rates when they inseminated 25 x 106 progressively 
motile sperm (PMS) in a 1-mL volume (57%, 12/21), 5 x 106 PMS in a 1-mL volume 
(30%, 3/10), and 5 x 106 in a 0.2-mL volume (4/10, 40%) utilizing the TRG technique. A 
significant difference, however, did exist between the TRG pregnancy rates and the 
pregnancy rate obtained when 500 x 106 PMS was inseminated utilizing a conventional 
UBI (18/20, 90%). 
The third and less commonly used technique in a commercial setting is the 
ultrasound-guided intrauterine injection (UGIUI). It is a technique that was first 
developed to inject a treatment solution into the uterine lumen of non-pregnant mare 12 
days post-ovulation without traversing the mare’s cervix [24]. It was then modified into 
a method for embryo transfer [25,26] and DHI [25]. Utilizing a transvaginal probe 
handle fitted with a 5 MHz convex-array transducer and needle guide, Silva et al. [25] 
inserted a 17-gauge needle, containing an epidural catheter (0.85 x 0.45 x 1000 mm) 
preloaded with the inseminate and attached to a 1-mL syringe, through the vaginal fornix 
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into the tip of the uterine horn (positioned against the vaginal fornix against the 
transducer by transrectal manipulation). The epidural catheter was then passed to the tip 
of the uterine horn, semen was deposited, and the tip of the uterine horn was manually 
held in a ventral position for 3 minutes to facilitate pooling of semen against the 
oviductal papilla. These workers achieved a 50% (5/10) pregnancy rate with an 
insemination dose containing 20 x 106 progressively motile sperm. 
Each of these DHI techniques has advantages and disadvantages. The 
hysteroscopic technique allows direct visualization of the oviductal papilla prior to 
semen deposition. However, the equipment is expensive and requires proper cleaning 
and sterilization to prevent iatrogenic infection (e.g. Escherichia coli and Pseudomonas 
aeruginosa), especially from contamination of the internal channels of the endoscope 
[27-31]. In addition, care must be taken to ensure that disinfectant solutions do not leave 
spermicidal residues within or on the endoscope. The sterilization and washing 
procedure is lengthy, and with the potential of spermicidal residues, the endoscope 
cannot be sterilized between mares that require insemination within a short period of 
time. If cleaning is done improperly post-insemination, residual semen may remain 
within the biopsy channel of the endoscope, creating the potential for inseminating with 
the wrong stallion’s semen when the endoscope is used to breed with semen from more 
than one stallion. Another consideration is the possibility of inseminating the incorrect 
uterine horn if insemination is based only on visualization; this is the primary reason 
Lindsey et al. [17] advocated confirming endoscope location transrectally prior to 
deposition of semen.  
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The TRG technique avoids the need for expensive equipment but does not allow 
visualization to confirm that direct semen deposition onto the oviductal papilla has 
occurred. To compensate for this weakness, some proponents of TRG advocate holding 
the tip of the uterine horn in a ventral location during and for a short time after 
insemination to allow pooling of the inseminate on or near the oviductal papilla. 
Transrectally guided deep-horn insemination has the benefit of using a sterile disposable 
insemination pipette, eliminating the possibility of contamination of the uterus from the 
equipment and the need to clean or sterilize equipment between uses. It can be 
performed in a relatively short period of time but does require greater expertise than 
HYS to obtain optimal results. 
The UGIUI technique is probably the most invasive of the three DHI techniques. 
It does not allow direct visualization of the oviductal papilla, but semen deposition can 
be visualized ultrasonographically. As with TRG, the tip of the uterine horn can be held 
in a ventral location during and after insemination, thereby theoretically allowing 
pooling of the inseminate on or near the oviductal papilla. It probably requires the 
greatest expertise of all three DHI techniques but once the expertise is possessed it is 
reported to only take approximately 48 seconds from insertion of the UGIUI equipment 
into the vagina to completion of the procedure [25]. Like the HYS technique, UGIUI 
requires relatively expensive equipment that requires proper cleaning and sterilization 
with the associated risks and labor costs (as described above with HYS). Even if rare, the 
risk of introducing bacteria into the peritoneal cavity seems possible since the UGIUI 
equipment is likely to become contaminated with bacteria from the caudal reproductive 
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tract [32] before the needle is introduced into the peritoneal cavity. Due to its procedure 
similarities to transvaginal aspiration of ovarian follicles, the risk of severe internal 
hemorrhage is also a rare but potential possibility with UGIUI [33]. 
Whether DHI results in the development or prevention of endometritis has been 
controversial. Lindsey et al. [17] suggested that the manipulation required to pass the 
pipette to the tip of the uterine horn with TRG could traumatize the endometrial wall, 
creating an inflammatory environment unsuitable for sperm survival and embryonic 
development. Schiemann et al. [34] reported that endoscopic examination of the diestrus 
uterus and the associated necessity of distending the uterus with air resulted in a 100% 
incidence (8/8) of histopathologic endometritis with isolation of pathogenic bacteria in 
six of these mares five days after the procedure, suggesting that the hysteroscopic 
procedure is inflammatory to the uterus and may be associated with induction of 
bacterial endometritis. When Sieme et al. [4] compared pregnancy rates following 
insemination of fresh semen in a clinical setting, he reported that HYS (5/15, 33%) 
resulted in lower pregnancy rates than UBI (16/19, 84%) in problem mares, but no effect 
of insemination technique was noted in normal mares (27/38, 71% and 18/38, 47%, 
respectively). These findings suggest that detrimental effects of the hysteroscopic 
procedure might be especially pronounced in mares with suboptimal uterine 
environments.  
Controlled studies evaluating the relationship of DHI to endometritis have shown 
that DHI does not induce more inflammation within the uterus than does conventional 
UBI in reproductively normal mares [35,36]. Güvenc et al. [35] evaluated the amount of 
 7 
 
inflammation present in the uterine lumen of normal mares 24 h post-insemination with 
20 x 106 and 200 x 106 sperm (0.5 mL) following UBI or TRG (i.e. 4 treatment groups). 
Specifically, they evaluated the amount of intrauterine fluid present ultrasonographically 
(compared to amount present at time of insemination), then obtained uterine fluid 
samples by first absorbing fluid into a tampon and then performing uterine lavage. The 
uterine fluid was analyzed for aerobic microbial growth, number of polymorphonuclear 
leukocytes per mL (PMN/mL), and lysozyme and trypsin-inhibitor capacity (TIC) levels. 
These investigators concluded that TRG and insemination dose (concentration) did not 
affect the level of inflammation 24 h post-insemination in normal mares. Ferrer et al. 
[36] evaluated the amount of inflammation present in normal mares and in mares with 
delayed uterine clearance 48 h post-insemination with either 1 x 109 sperm (20 mL) with 
UBI, 5 x 106 sperm (0.5 mL) with HYS, semen extender (0.5 mL) with HYS, or sperm-
free seminal plasma (0.5 mL) with HYS. Severity of the inflammatory response was 
determined by ultrasonographically evaluating the amount of intrauterine fluid at 24 and 
48 h post-insemination, and by evaluating the total number, concentration, and 
percentage of neutrophils in intrauterine fluid samples collected 48 h post-insemination 
with a tampon. The severity of post-breeding inflammation 48 h post-insemination did 
not differ between UBI and HYS in normal and delayed clearance mares. Delayed 
clearance mares, however, had more intrauterine fluid following HYS than following 
UBI at 24 h post-insemination. These investigators concluded that HYS was not 
contraindicated in mares with delayed uterine clearance, but that it should not be used as 
method to reduce post-breeding endometritis in these mares. 
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Results of HYS and TRG studies in 1998 and 2000 [15,23] did not support the 
use of DHI over a conventional uterine body insemination. Two studies presented at the 
2002 International Symposium on Equine Reproduction [37,38], however, indicated that 
use of DHI could allow fewer sperm to be used than was needed for conventional UBI, 
with comparable pregnancy rates. In 2003, Morris et al. [39] substantiated these 
findings. Utilizing 86 mares inseminated with frozen-thawed semen from identical twin 
stallions, they found that pregnancy rates with 14 x 106 PMS were not significantly 
different between mares inseminated utilizing conventional UBI (8/12, 67%) or HYS 
(9/14, 64%) techniques. When the insemination dose was decreased to 3 x 106 PMS 
sperm, deposition of semen into the tip of the uterine horn ipsilateral to the preovulatory 
follicle resulted in higher pregnancy rates (16/34, 47%) than did deposition of semen 
immediately cranial to the internal cervical os (2/14, 14%), or at the tip of the uterine 
horn contralateral to the preovulatory follicle (1/12, 8%). An endoscopic technique was 
used for insemination at all 3 of these sites to eliminate confounding factors created by 
its use. These findings indicated that the benefits of HYS are not seen until the 
insemination dose contains less sperm than needed to achieve acceptable pregnancy rates 
with UBI.  
Morris et al [40] further showed that a threshold level of sperm numbers exists 
that even HYS cannot overcome to sustain optimal pregnancy rates. In this study, 
optimal pregnancy rates were achieved when mares were inseminated with 10 x 106 
(60%), 5 x 106 (75%), or 1 x 106 (64%) fresh motile sperm following Percoll® (Sigma 
Chemical Co., St. Louis, MO, USA) gradient separation (to improve sperm quality 
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within the inseminate) from two stallions. Pregnancy rates were less when the 
insemination dose was decreased to 0.5 x 106 (29%), 0.1 x 106 (22%), and 0.001 x 106 
(10%). 
Studies examining the motility and morphology of the sperm found in the 
oviducts of mares post-insemination have shown the presence of a higher percentage of 
sperm with normal morphology [41] and motility [42,43] than was present within the 
inseminate. Scott et al. found that morphologically normal sperm accumulate in the folds 
of the oviductal papilla, suggesting that the uterotubal junction (UTJ) may act as a sperm 
reservoir and “gatekeeper” to the oviduct [44]. Mares bred to subfertile stallions had 
fewer sperm in their oviducts 4 h after breeding than did mares bred to fertile stallions 
[41]. These studies suggest that increasing the reservoir of morphologically normal, 
motile sperm on the UTJ and within the oviduct could potentially enhance fertility 
especially in circumstances where subfertile semen is involved. The above described 
studies, however, did not evaluate other measures of sperm quality in the population of 
sperm found within the oviducts. 
Woods et al. [45] were not able to increase the pregnancy rates of a stallion with 
teratospermia (18-26% morphologically normal sperm) by changing the site of 
insemination of 25 x 106 total sperm from the uterine body (4/14, 29%) to the tip of the 
uterine horn (4/14, 29%). Mari et al. [12] improved per cycle pregnancy rates for a 
commercial breeding stallion with teratospermia and oligospermia via implementation of 
TRG with 50 x 106 morphologically normal, progressively motile sperm (1 mL). Semen 
was processed with cushion (iodixanol solution) centrifugation alone or in combination 
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with discontinuous density gradient centrifugation (90:45% silicon coated silica colloids, 
RediGradTM; Amersham Biosciences, NJ, USA). To obtain an insemination dose of 50 x 
106 morphologically normal, progressively motile sperm, ~500 x 106 post-centrifugation 
sperm or ~130 x 106 RediGradTM purified sperm were needed. The semen processed 
through the RediGradTM (44/71, 62%) resulted in higher pregnancy rates than did the 
semen processed with cushion centrifugation only (30/71, 42%). Both pregnancy rates 
were, however, better than that for the previous season (27/105, 26%). The study 
suggests that the presence of abnormal sperm interferes with normal fertilization or with 
development of a viable pregnancy. It also suggests that selecting for sperm quality prior 
to insemination could enhance fertility of some stallions. Similar improvements in 
fertility have been reported with semen processed with cushion (iodixanol solution) 
centrifugation only and with cushion centrifugation followed by discontinuous (80:40% 
density gradient) or single-layer (80% density gradient) density gradient centrifugation 
with the colloidal silica-particle solution EquiPureTM (80% density gradient, EquiPure 
Bottom LayerTM; 40% density gradient, EquiPure Top LayerTM; Nidacon International 
AB, Mölndal, Sweden) [10,11,14]. 
Studies comparing the relative effectiveness of HYS and TRG (but not UGIUI) 
have been performed. Lindsey et al. [17] reported higher pregnancy rates with HYS 
(5/10, 50%) than with a modified TRG technique (0/10, 0%) following insemination of 5 
x 106 motile sperm following Percoll® gradient separation. Brinsko et al. [46] reported 
no difference between HYS and TRG (12/18, 66% and 10/18, 56%, respectively) 
following insemination of 5 x 106 total sperm (3.1 – 3.9 x 106 progressively motile 
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sperm). In a follow-up study utilizing the TRG technique described by Brinsko et al. 
[46], Lindsey et al. [18] reported no difference in pregnancy rates (12/22, 56% and 9/24, 
38%, for HYS and TRG, respectively) following insemination with 20 x 106 sex-sorted 
sperm. Nevertheless, based on the earlier paper by Lindsey et al., it was suggested that 
HYS may be the preferred method of DHI when less than 25 to 50 x 106 sperm are used, 
especially if the semen is frozen-thawed or sex-sorted [47]. 
The findings of the above-referenced studies indicated that differences in 
pregnancy rates related to insemination technique may not be detected if “excess” sperm 
are available to compensate for limitations in the technique [48,49]. Thus, to best 
demonstrate differences between techniques, assessment should be made using a 
subthreshold number (i.e. subfertile level) of sperm. The importance of utilizing 
subthreshold insemination doses was demonstrated by Morris et al. [39] in their 
comparison of uterine insemination sites (described above). Previous studies comparing 
HYS to TRG have not been conducted using subthreshold insemination doses.  
The objective of the studies reported here was to determine if HYS or TRG 
techniques provided equivalent pregnancy rates when a subfertile dose of sperm was 
inseminated. A preliminary study was performed to identify an insemination dose below 
the threshold level for normal pregnancy rates for one particular stallion. The objective 
of the main study was to compare the pregnancy rates achieved after HYS or TRG 
techniques utilizing a subthreshold insemination dose from this stallion. 
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I.2. Effects of High Dilution on Sperm Quality 
To perform the low-dose inseminations performed in the deep-horn 
insemination study, the semen was diluted to 2.5 to 5 million sperm/mL. 
Excessive dilution of semen (below 20 million sperm/mL) has been demonstrated 
to have detrimental effects on sperm quality especially as duration of exposure to 
the diluent increases. This phenomenon known as the “dilution effect” was first 
described by Milovanov in 1934 [50]. He evaluated the ability of sperm within an 
ejaculate to resist immobilization following dilution with increasing proportions 
(volume of diluent to volume semen) of 1% sodium chloride. 
Multiple hypotheses have been made regarding etiology of the “dilution 
effect.” Milovanov [50] attributed the loss of sperm motility to sodium chloride 
toxicity. Subsequent researchers proposed that it is due to the loss of adequate 
proportions of protective seminal plasma components [51-54], and/or intracellular 
and/or cell-surface components from the sperm [51-53,55-58] triggering a 
capacitation-like state and ultimately premature acrosome reaction [59]. 
Researchers studying the hydrodynamics of sperm motility have postulated an 
alternative hypothesis: they determined that the flagellar undulations of sperm 
induce motions in the fluid medium that move enzymes, ions, and other dissolved 
chemicals and gases to and from the plasma membranes of other sperm in close 
proximity, especially when sperm are within one body length from each other. As 
sperm concentration decreases, the distance between sperm is increased, which 
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results in impaired exchange of the components within the liquid medium that are 
important to maintain sperm viability [60] 
The “dilution effect” has been described in multiple species including the 
rabbit [51,52,55,61], ram [52,54,57,61], bull [52,56-58,62-66], boar [59], dog 
[53], stallion [67,68], and human [52,69]. In all these species, this phenomenon 
occurs when the neat semen in diluted to less than 20 million sperm/mL [51-
59,61,65,66,69,70]; even though neat semen concentration [71], diluent type and 
seminal plasma concentration varies within species and individuals. Ejaculates 
with low neat semen concentrations, however, tend to have more severe effects 
than do ejaculates with high neat semen concentrations at equivalent dilution rates 
(v:v), suggesting that a lower final sperm concentration is more detrimental to 
sperm quality than is simply dilution of seminal plasma [62,65,66,69,70]. 
Regardless of initial sperm concentration, the severity of the “dilution effect” 
appears to increase as the diluent to neat semen ratio (v:v) increases [51-59,61-
66,69].  
The type of diluent used does not appear to alter the concentration at 
which the “dilution effect” is seen; however, it does influence the severity of the 
effect [52-59,61,63,64,66,69,72]. Seminal plasma is not a suitable diluent for 
maintenance of sperm quality [58,69,70,73]. Supplementation of seminal plasma 
to other diluents, however, has reduced the detrimental effects of high dilution on 
sperm motility (rabbit [55], bull [57,58], ram [57], and dog [53]), plasma 
membrane integrity (ram [54], bull [66], and boar [59]), and mitochondrial 
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membrane potential (bull [66] and boars [59]). Isotonic semen diluents with 
suitable levels of buffers, electrolytes, energy sources and antibiotics have been 
found to improve the overall sperm quality of extended semen samples and to 
diminish the severity of the “dilution effect” [54]. High molecular weight 
compounds such as egg yolk [56], milk [70], and serum proteins [61,74] exhibit 
protective effects on highly diluted semen and are common components of the 
above semen diluents. 
When comparing motility of rabbit sperm following dilution with Baker’s 
solution to 20, 2.8, 0.4 and 0.06 x 106 sperm/mL, Emmens and Swyer [55] 
reported that sperm motility decreased as the level of dilution increased. Adding 
sperm-free seminal plasma to the Baker’s solution at a concentration (v:v) 
equivalent to the 20 x 106 sperm/mL suspension improved sperm motility at the 
0.4 x 106 sperm/mL concentration. Further improvements in sperm motility were 
seen when the source of the Baker’s solution and seminal plasma diluent was the 
supernatant of a semen suspension allowed to incubate overnight at a 
concentration of 20 x 106 sperm/mL, but sperm motility did not necessarily return 
to the level of the 20 x 106 sperm/mL suspensions. These findings suggest a 
partial protective effect of seminal plasma in Baker’s solution especially when the 
seminal plasma may contain factors released either from the sperm plasma 
membrane or from within the sperm.  
 To evaluate the effect of diluent to seminal plasma ratio in the highly 
diluted samples, Emmens and Swyer [55] subjected 20 x 106 sperm/mL 
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suspensions (diluted in Baker’s solution) to two centrifugation treatments 
followed by resuspension to 20 x 106 sperm/mL with either fresh Baker’s solution 
or its own supernatant. The semen resuspended in the Baker’s solution was 
estimated to have equivalent diluent to seminal plasma ratios as the 0.6 x 106 
sperm/mL simple dilution samples (described in the previous paragraph). This 
semen resulted in higher sperm motilities than did the semen resuspended in its 
own supernatant. However, if all of the seminal plasma was removed utilizing six 
centrifugation treatments followed by resuspension with fresh Baker’s solution to 
20 x 106 sperm/mL, sperm motility was almost completely eliminated. 
Resuspension of the sperm following the final centrifugation with Baker’s 
solution containing 10% seminal plasma revitalized the motility to the level of the 
control semen sample (centrifuged semen resuspended into its own supernatant). 
The better motility of 20 x 106 sperm/mL than 0.4 sperm/mL preparations at the 
same seminal plasma concentration suggests that the lower sperm motility in the 
0.4 x 106 sperm/mL suspension is likely due to a lower sperm concentration. 
Secondly, sperm motility was improved in Baker’s solution when seminal plasma 
was present, but the amount of seminal plasma needed was very small (present 
after 2 centrifugation but not after 6 centrifugations). Finally, the findings of this 
study demonstrate that immotile does not mean “dead” and that Baker’s solution 
containing 10% seminal plasma can rejuvenate motility of sperm immobilized by 
the lack of seminal plasma.  
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Garner et al. [65] evaluated plasma membrane integrity (SYBR-14 and 
propidium iodide), mitochondrial membrane potential (JC-1), and motility of bull 
sperm following 24 h of cool-storage (5°C) or after cryopreservation at 2, 10, 20, 
40, and 60 x 106/mL. They found that all three sperm parameters decreased as the 
level of dilution increased. The plasma membrane integrity was more severely 
affected than the mitochondrial membrane potential and the motility. 
Supplementing the lower four semen concentrations with seminal plasma at the 
concentration (v:v) found in the 60 x 106 sperm/mL reduced the severity of 
damage to plasma membrane integrity, mitochondrial membrane potential and 
motility but did fully eliminate the “dilution effect.” 
No studies evaluating the “dilution effect” in stallions at less than 20 x 106 
sperm/mL on in vitro semen parameters were found on literature search. Varner et 
al. [70] evaluated the effects of simple dilution of stallion semen with a skim 
milk-glucose extender (Kenney extender) to concentrations greater than 20 x 106 
sperm/mL (25, 50, and 100 x 106 sperm/mL; control = undiluted semen) on sperm 
motility following room-temperature (25°C) storage for 0.5, 3, 6, 12, and 24 h. 
They further evaluated the effects of neat semen concentration and seminal 
plasma content by comparing the motility of the sperm-rich fraction to that 
representative of the total ejaculate (sperm-rich fraction diluted 1:1 with the 
sperm-poor). Over all of the dilutions, mean total sperm motility at 12 and 24 h of 
storage and mean progressively motility at 24 h was greater in the sperm-rich 
fractions than in the total ejaculate. In addition, mean total sperm motility was 
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higher at 25 x 106/mL than at 50 x 106/mL starting at 12 h of storage, higher than 
at 100 x 106/mL starting at 3 h of storage, and higher than that for undiluted 
samples starting at 0.5 h of storage. The 25 x 106/mL treatment also had higher 
mean progressive motility than did the other three semen concentrations following 
3 to 24 h of storage. The changes in motility in this study were not due to the 
“dilution effect” as the 25 x 106/mL samples performed better than the less dilute 
samples. They were due either to higher sperm concentration causing reduction of 
motility, possibly due to accumulation of metabolic byproducts, or to the higher 
percentage of seminal plasma (v:v) in the more concentrated samples, with higher 
levels of seminal plasma resulting in lower sperm motility parameters especially 
as storage time increased. 
The percentage of seminal plasma in a semen suspension that optimizes 
semen quality following storage is dependent on the composition of the diluent. In 
Kenney (skim-milk/glucose) -based extenders, sperm motility is optimized in 5 – 
20% seminal plasma (v:v) [75]. However, when Kenney-based extender is 
supplemented (65:35) with high-potassium Tyrode’s medium (KMT), sperm 
motility is optimized when all seminal plasma is removed from the semen 
suspension [76-78]. DNA integrity following 24 and 48 h of cool-storage (5°C), 
however, is optimized in both the Kenney-based and KMT extenders when no 
seminal plasma is present [78]. 
Insemination of stallion semen at less than 20 x 106 sperm/mL, the sperm 
concentration where the “dilution effect” is seen in vitro in other species, has had 
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mixed effects on fertility. In one study, conventional UBI of 250 x 106 PMS 
resulted in both lower and similar pregnancy rates when the sperm concentration 
was 5 x 106 PMS/mL (50 mL) compared to a 25 x 106 PMS/mL (10 mL); 
however, different stallions were used in this study which may account for 
differences in pregnancy rates [67]. In another study, pregnancy rates were lower 
with UBI of 250 x 106 PMS at 2.5 x 106 PMS/mL (100 mL) compared to 25 x 106 
PMS/mL (10 mL) [68]. It is not clear what may have caused this lower fertility 
since total sperm numbers in the inseminate were not reported.. The “dilution 
effect” may have reduced the sperm quality, but other possibilities suggested by 
the authors include retrograde sperm loss due to expulsion of the higher volume 
treatment resulting in an effectively lower sperm dose, or detrimental effects 
directly related to instilling large volumes of semen. This latter possibility was 
later disproven [79].  
Because of the limited information available on the effect of dilution on 
equine sperm viability and motility, and its direct relationship to use in low-dose 
insemination programs, a study was conducted to evaluate the in vitro quality of 
stallion sperm subjected to the high levels of dilution. Sperm parameters 
evaluated included sperm motion characteristics and plasma membrane integrity.  
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CHAPTER II 
PREGNANCY RATES IN MARES INSEMINATED WITH  
0.5 OR 1 MILLION SPERM USING HYS OR TRG* 
 
II.1. Materials and Methods 
 A preliminary study and a main study were conducted to compare the pregnancy 
rates associated with two different deep-horn insemination techniques, TRG and HYS, 
when a subthreshold insemination dose was used. The experiments were conducted 
during the summer and fall months of 2007 and 2008. All experimental procedures were 
performed according to the United States Government Principles for Utilization and 
Care of Vertebrate Animals Used in Testing, Research and Training and were approved 
by the Laboratory Animal Care Committee at Texas A&M University. 
The preliminary study was conducted to identify the number of total sperm in an 
insemination dose that would result in suboptimal pregnancy rates for a specific stallion. 
The stallion, a 1989 American Quarter Horse, was a stallion of known high fertility. This 
stallion was selected to eliminate possible confounders being introduced by male-factor 
subfertility. 
 The subsequent study compared pregnancy rates at Days 14 to 16 after ovulation 
following TRG and HYS utilizing the subthreshold insemination dose identified in the  
_____________________ 
 
*Part of this chapter is reprinted with permission from Hayden SS, Blanchard TL, Brinsko SP, Varner DD, 
Hinrichs K, Love CC. Pregnancy rates in mares inseminated with 0.5 or 1 million sperm using 
hysteroscopic or transrectally guided deep-horn insemination techniques. Theriogenology 2012;78:914-20. 
Copyright 2012 by Elsevier Publishing. 
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preliminary study. Mares with complicating reproductive factors were excluded from 
this study to eliminate possible confounders being introduced by female-factor 
subfertility. In this study, each mare was inseminated with each deep-horn insemination 
technique in a cross-over design to control for the effect of the mare. 
II.1.1. Preliminary study  
II.1.1.1. Mare management  
 Twenty-eight mares ranging in age from 3 – 18 yrs (mean 6.5; median 6) were 
inseminated utilizing either TRG or conventional uterine body insemination for a total of 
44 estrous cycles. Mares were monitored from August through October of 2007 utilizing 
palpation and ultrasonographic evaluation (B-mode, real time ultrasonography, 5MHz 
linear transducer, Sonovet 600; Universal Solutions, Inc., Bedford Hills, NY, USA) of 
the reproductive tract per rectum to determine estrous cycle stage. Sexual receptivity to a 
stallion was also intermittently assessed to facilitate determination of estrous cycle stage. 
Evaluations were performed only on weekdays as the mares were inaccessible on the 
weekends.  
If the mares had a preovulatory follicle ≥32 mm in diameter and prominent signs 
of uterine edema on ultrasonography, the mare was treated with human chorionic 
gonadotropin (hCG; Chorulon®; Intervet, Millsboro, DE, USA; 2500 IU, iv), or 
BioRelease Deslorelin (BET Pharm, Lexington, KY, USA; 1.5 mg, im). The same day or 
the following day, if a preovulatory follicle was still present, mares were inseminated 
with 1.0 x 106 or 0.5 x 106 total sperm utilizing TRG, or with a minimum of 1 x 109 
progressively motile sperm utilizing conventional uterine body insemination. With the 
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TRG method, sperm were inseminated in the horn ipsilateral to the dominant follicle. In 
mares with more than one follicle >30 mm, the sperm were placed in the horn ipsilateral 
to the follicle showing the most pronounced preovulatory characteristics (softness on 
palpation, thickening of the follicle lining and loss of circularity on ultrasonographic 
evaluation). Mares were inseminated only once per cycle. Ovulation was confirmed by 
daily transrectal ultrasonographic examination except when these examinations would 
have occurred over the weekend; then ovulation was confirmed the following Monday. 
Pregnancy determination was made utilizing transrectal palpation and ultrasonography 
13 to 16 days from the first day that the ovulation was detected (n = 42) or following 
uterine flush for embryo recovery 7 days post-ovulation (n = 2). Mares determined to be 
pregnant 13 to 16 days post-ovulation and mares subjected to uterine flush 7 days post-
ovulation were treated with cloprostenol sodium (Estrumate®; Schering-Plough Animal 
Health Corp., Union, NJ, USA; 250 µg, im), or dinoprost tromethamine (Lutalyse®; 
Upjohn Pharmacia, Kalamazoo, MI, USA; 5 mg, im) to terminate pregnancy unless 
continuation of pregnancy was desired for other purposes (e.g., fetal sexing laboratory). 
Non-pregnant mares 13 to 16 days post-ovulation were either administered the same 
luteolytic regimen as for the pregnant mares, to return the mare to estrus, or they were 
allowed to return to estrus naturally. 
If the mares were not found in estrus after this time, they were periodically 
monitored as described above until they returned to estrus naturally, or they were treated 
with a luteolytic agent to terminate the luteal phase and return them to estrus. If it was 
known that the most recent ovulation occurred ≥7 days previously, the mare was 
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scheduled for recheck evaluation 1 to 4 days later based on the diameter of the largest 
follicle (40 to <15 mm, respectively). If it was not known, when the mare last ovulated, 
the mare was re-evaluated 1 to 3 days after treatment with a luteolytic agent to determine 
whether luteolysis had occurred. In some mares, during the estrus following luteolysis, 
ovulation was induced by treatment with hCG, then luteolytic treatment was 
administered 7 days after this ovulation, and mares were used for the study on the 
subsequent estrus. 
In this preliminary study, the insemination technique used was dictated based on 
the needs of the TAMU Section of Theriogenology. If it was imperative that the mares 
became pregnant (i.e. for the use in laboratories and other research projects), 
conventional uterine body insemination utilizing ≥1.0 x 109 progressively motile sperm 
was performed to optimize fertility rates. Otherwise, mares were bred with TRG. The 
dose used in the TRG breeding was not randomized; rather, it was determined based on 
equality of number of mares inseminated with each dose (e.g., if there were 2 more 
mares inseminated with one dose, the next 2 mares would be inseminated with the other 
dose). 
II.1.1.2. Semen collection   
Semen was collected from stallions using a Missouri-model artificial vagina 
(Nasco, Ft. Atkinson, WI, USA) lightly lubricated with 3 – 5 mL of sterile, non-
spermicidal lubricating jelly (Priority Care; First Priority, Inc., Elgin, IL, USA) and 
fitted with an in-line nylon gel filter (Animal Reproduction Systems, Chino, CA, USA). 
A mare exhibiting behavioral estrus was used for sexual stimulation. The mount source 
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was a breeding phantom. Immediately prior to collection, the stallion’s erect penis was 
cleansed with warm water and thoroughly dried. 
II.1.1.3. Semen processing  
II.1.1.3.1. General semen processing 
Immediately following semen collection, the gel filter was removed from the 
collection bottle to prevent leakage of the gel into the gel-free semen. The gel-free 
semen was transported to an adjacent laboratory and placed in a 37°C incubator. The 
total number of sperm in the ejaculate was determined by measuring the volume of the 
neat semen using a 100-mL graduated cylinder and measuring the concentration using 
the NucleoCounter® SP-100TM (ChemoMetec A/S, Allerød, Denmark). 
An aliquot of neat semen was diluted with pre-warmed (37°C) semen extender 
(INRA 96; IMV, Maple Grove, MN, USA) to a final concentration of 30 x 106 
sperm/mL and a volume of 1.0 mL in a 1.2-mL Cryogenic vial (Corning Life Sciences, 
Lowell, MA, USA) using the following formulas: 
 Volume of raw semen required = (30 x 106 sperm/mL) ÷ (raw semen 
concentration) * (1.0 mL) 
 Volume of extender = (1.0 mL) - (volume of raw semen required) 
The Cryogenic vial was placed directly on a 37°C covered slide warmer for 10 minutes 
prior to evaluation of initial sperm motion characteristics using a computer-assisted 
sperm motion analyzer (CASMA; IVOS Version 12.2L; Hamilton Thorne Biosciences, 
Beverly, MA, USA). 
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II.1.1.3.2. Semen processing for deep-horn insemination dose  
 A 3:1 extended semen sample was made by adding 0.5 mL of neat semen to a 
2.0-mL Cryogenic vial (Corning Life Sciences, Lowell, MA, USA) containing 1.5 mL of 
pre-warmed (37°C) INRA 96. The concentration of this 3:1 extended semen sample was 
measured using the NucleoCounter® SP-100TM. 
 To obtain TRG insemination doses of 1 x 106 and 0.5 x 106 sperm in 200 µL, 
final dilution of semen to 5 x 106 or 2.5 x 106 sperm/mL, respectively, was made. 
Depending on the number of mares to be bred that day, a 1- or 2-mL aliquot of semen at 
the above concentrations was made utilizing the 3:1 extended semen sample, pre-
warmed (37°C) INRA 96, and frozen-thawed, sperm-free seminal plasma to ensure that 
each inseminate contained 7.5% seminal plasma [75,77,80]. The amount of each of these 
components was determined using the following formulas: 
 volume of sample desired = X + Y + Z 
 X = volume of 3:1 extended semen 
 Y = volume of INRA 96 
 Z = volume of frozen-thawed sperm-free seminal plasma 
 X = (concentration of sample desired) ÷ (concentration of 3:1 extended 
semen) * (volume of sample desired)  
 combined amount of INRA 96 and frozen-thawed, sperm-free seminal 
plasma = (volume of sample desired) - X 
 % of seminal plasma in final inseminate if no seminal plasma was added = 
[(25%) * (X) ÷ (volume of sample desired)] * 100 
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 % of seminal plasma in INRA 96 to make a final inseminate containing 7.5% 
seminal plasma = 7.5% - (% of seminal plasma in final inseminate if no 
seminal plasma was added) 
 Z = (combined amount of INRA 96 and frozen-thawed, sperm-free seminal 
plasma) * (% of seminal plasma in INRA 96 to make a final inseminate 
containing 7.5% seminal plasma) 
 Y = (combined amount of INRA 96 and frozen-thawed, sperm-free seminal 
plasma) - Z  
For example, to make 1.0 mL of an inseminate that was 5 x 106 sperm/mL from a 3:1 
semen sample that was 75 x 106 sperm/mL: 
 X = (5.0 x 106 sperm/mL) ÷ (75 x 106 sperm/mL) * (1.0 mL) 
 0.067 mL = volume of 3:1 extended semen 
 combined amount of INRA 96 and frozen-thawed, sperm-free seminal 
plasma = (1.0 mL) – (0.067 mL) 
 0.933 mL 
 % of seminal plasma in final inseminate if no seminal plasma was added = 
[(25%) * (0.067mL) ÷ (1.0 mL)] * 100 
 1.67% 
 % of seminal plasma in INRA 96 to make a final inseminate containing 7.5% 
seminal plasma = (7.5%) – (1.67%) 
 5.83% 
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 Z = (0.933 mL) * (5.83%) 
 0.054 mL = volume of frozen-thawed, sperm-free seminal plasma 
 Y = (0.933 mL) – (0.054 mL) 
 0.879 mL = volume of INRA 96 
The concentrations of the insemination doses were evaluated using the NucleoCounter® 
SP-100TM. Samples not within 0.3 x 106/mL of the desired final concentration were 
discarded. Calculations were checked twice. If samples were discarded new 
insemination doses were made, and evaluated using the procedures as previously 
described. 
II.1.1.3.3. Semen processing for conventional uterine body insemination dose  
 A minimum of 1 x 109 progressively motile sperm was diluted with INRA 96 to 
make an insemination dose that contained ≥1 part INRA 96 to 1 part neat semen (v:v) 
and had a final volume of 10 – 60 mL. Fulfilling this criteria meant that the maximum 
volume of neat semen per insemination dose was ≤30 mL. 
The following formula was used to determine the minimum volume of neat 
semen needed to make an insemination dose that contained ≥1 x 109 progressively 
motile sperm: 
 Volume of neat semen containing 1 x 109 progressively motile sperm =        
(1 x 109) ÷ [(neat semen concentration) * (% of progressively motile sperm)] 
If the entire ejaculate was used for insemination, the volume of neat semen per 
insemination dose was determined using the following formula: 
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 Maximal volume of neat semen available per insemination = [(total volume 
of neat semen in ejaculate) * (volume of neat semen in ejaculate) * (% of 
progressively motile sperm)] ÷ (number of mares requiring insemination) 
Based on the results of these two formulas and the above defined criteria, the appropriate 
volume of neat semen was diluted with the appropriate amount of INRA 96. The product 
was aspirated into either a 25 mL or 60 mL non-spermicidal, all-plastic, sterile syringe 
(NORM-JECT®; Henke Sass Tolf, Tuttlingen, Germany). The extended semen was 
inseminated utilizing a conventional uterine body insemination within one hour of semen 
collection. 
II.1.1.4. Inseminations  
II.1.1.4.1. General insemination protocol 
The mares were placed in stocks for restraint. No tranquilization was used. The 
mares’ tails were bagged in non-sterile rectal sleeves and tied up, and their perinea were 
prepared by scrubbing with 7.5% povidone-iodine surgical scrub, rinsing with water, and 
drying with paper towels. 
II.1.1.4.2. Transrectally guided deep-horn insemination (TRG)  
 Transrectally guided deep-horn insemination was performed as described by 
Brinsko et al. [46], except that a commercially available 75 cm flexible, intrauterine 
insemination catheter with an 80 cm flexible inner catheter (IUI Pipette with Inner 
Catheter; Minitube of America, Inc.TM, Verona, WI, USA) (Figure 1) attached to a 5 mL 
non-spermicidal, all-plastic, sterile syringe (NORM-JECT®; Henke Sass Wolf, 
Tuttlingen, Germany) was used. The syringe was preloaded with 3 mL of air. A sterile 
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sleeve was donned. Two hundred microliters of semen, as described in section II.1.1.3.2, 
was aspirated into an air-displacement pipette (PIPETMAN ClassicTM P200; Gilson®, 
Inc., Middleton, WI, USA). The distal tip of the air-displacement pipette was inserted 
into the lumen of the tip of the 80 cm flexible inner catheter. The pipette plunger was 
slowly depressed as gentle negative pressure was gently applied by the syringe plunger. 
Care was taken to keep the semen at the distal end of the inner catheter (i.e. the end 
furthest from the syringe). The inner catheter was re-inserted into the outer catheter. The 
entire double catheter was bent 5 cm from the distal end to an approximate 45o angle. 
The catheter was carried transvaginally (Figure 2) and passed through the cervix. The 
arm was withdrawn from the vagina, inserted into the rectum (Figure 3), and the catheter 
was guided transrectally to the tip of the uterine horn ipsilateral to the dominant follicle. 
When the end of the catheter was confirmed by palpation to be at the end of the uterine 
horn, the plunger of the 5-mL syringe was depressed slowly to expel the semen into the 
uterine lumen (Figure 4). The syringe was detached, loaded with 3 mL of air, reattached, 
and then the air was expressed slowly through the catheter to aid in full evacuation of the 
contents. The inner catheter with the syringe attached was removed through the outer 
catheter, and evaluated for presence of semen (Figure 5). If semen was visible in the 
inner catheter, it was inserted again, and the process was repeated. After withdrawal of 
the inner catheter, the contents of the outer catheter were also evacuated (in case any 
semen pooled in the end of the outer catheter) by injecting 5 mL of air through the outer 
catheter (Figure 6). The tip of the uterine horn was directed ventrally via manipulation 
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per rectum throughout these procedures, and was held in this position, if possible, for up 
to 3 min after removal of the insemination device (Figure 7). 
 
Figure 1. The 75 cm flexible, intrauterine insemination catheter with an 80 cm flexible 
inner catheter (IUI Pipette with Inner Catheter; Minitube of America, Inc.TM, Verona, WI, 
USA). 
 
 
 
 
Figure 2. The insemination catheter was passed transvaginally through the cervix into 
the uterus. Note the attached 5-mL syringe containing 3 mL of air to the catheter. 
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Figure 3. Insertion of the operator’s arm in the rectum (after the catheter has been passed 
transvaginally in the uterus). 
 
 
 
 
 
Figure 4. Slow depression of the 5-mL syringe plunger following confirmation of 
placement of the tip of the catheter at the end of the uterine horn ipsilateral to the 
preovulatory follicle. 
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Figure 5. Removal of the flexible inner catheter with examination of it for presence of 
semen. The inner catheter was reinserted into the outer catheter if semen was grossly 
visualized. 
 
 
 
 
 
Figure 6. Passage of 5 mL of air through the outer catheter (following removal of the 
inner catheter) to remove any semen that may have pooled within the tip of it. 
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Figure 7. Removal of the outer catheter as the operator held the tip of uterine horn 
ipsilateral to the preovulatory follicle in a ventral position per rectum. Ventral orientation 
of the tip of the uterine horn was done throughout the insemination and if possible, for up 
to 3 minutes after removal of the outer catheter.  
 
 
 
 
 
II.1.1.4.3. Conventional uterine body insemination (UBI)  
The 60-mL syringe containing the extended semen as described above was 
attached to a standard, sterile, equine insemination pipette. A sterile sleeve was donned. 
Five to six milliliters of air was aspirated into the semen syringe to aid in full evacuation 
of the semen from the syringe and insemination pipette. The insemination pipette was 
carried transvaginally and passed through the cervix. The distal end of the pipette was 
advanced into the cranial uterine body. To move the air bubble into a position that would 
allow it to “chase” all remaining semen from the syringe and pipette, the syringe tip was 
rotated to the 6 o’clock position and the plunger-end of the syringe was elevated to a 45° 
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angle. The cervix was held closed by the inseminator’s hand and the plunger was slowly 
depressed until all semen was expelled into the uterus. The inseminator’s arm was 
slowly withdrawn from the vagina to prevent aspiration of air into the vagina. 
II.1.1.5. Embryo recovery  
Two mares underwent uterine lavage for embryo recovery 7 days after ovulation. 
The mares were restrained and the perineum prepared in the same manner as described 
above in section II.1.1.4.1, with the addition that mares were sedated with detomidine 
(Dormosedan®; Pfizer, Lees Summit, MO, USA; 3 to 4 mg, iv). 
A sterile sleeve was donned. A sterile, equine lavage catheter (37 Fr, 75 mL, 36 
in; Bioniche Life Sciences, Inc., Belleville, Ontario, Canada) was connected to an equine 
Y-tube set with spike (Bioniche Life Sciences Inc., Belleville, Ontario, Canada). The 
spike was inserted in a bag containing ViGROTM Complete Flush Solution (Bioniche 
Life Sciences Inc., Belleville, Ontario, Canada) and the tubing was primed with flush 
solution. The equine lavage catheter was carried transvaginally and passed through the 
cervix. The catheter balloon was inflated with 30 – 40 mL of air. A sufficient volume of 
flush solution was instilled into the uterine lumen to entirely fill it (1 – 2 L). After 
approximately 200 – 500 mL of flush solution had been instilled, the operator’s arm was 
withdrawn from the vagina and inserted into the rectum. After the uterine lumen was 
distended fully, the fluid was held in place for 2 minutes. The flush solution was then 
removed from the uterus by gravity flow, through a 150-mL embryo collection cup fitted 
with a 75-µm nylon mesh filter (Millipore Non-Vented Embryo Collection Filter; 
Bioniche Life Sciences, Inc., Belleville, Ontario, Canada). The uterine flush was 
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repeated two more times but without delay in removing the solution from the uterus. The 
mare was treated with 20 IU oxytocin iv at the completion of the third influx of solution 
to improve myometrial contraction and facilitate complete removal of the solution from 
the uterus. The uterus was intermittently, ballotted manually per rectum during the 
flushing process in an attempt to suspend the uterine contents within the fluid. 
After the final flush, the catheter balloon was deflated and the lavage catheter 
was removed from the mare. With the flush catheter held in a vertical position with the 
tip uppermost, it was allowed to fill with flush solution to the level of the catheter 
balloon. The flush solution was then released through the efflux portion of the tubing 
into the embryo collection cup. This process was performed 2 – 3 times in an attempt to 
ensure that any embryo present no longer remained within the catheter and tubing.  
One centimeter depth of flush solution was maintained above the filter in the 
embryo collection cup. The cup was then transported into an adjacent laboratory. The 
cup was inverted and its contents were thoroughly rinsed into an embryo search dish 
(100 x 15 mm round searching grid dish; Bioniche Life Sciences, Inc., Belleville, 
Ontario, Canada) using a 20-mL all-plastic syringe fitted with a 20-gauge 1.5-in needle. 
The entire dish was systematically searched for the presence of an embryo ≥2 times 
using a stereo microscope (13.4-80x).  
II.1.2. Main study  
II.1.2.1. Mare management  
For this experiment, 37 mares ranging in age from 4 to 19 y (mean 9.2; median 
8) were used. The time of ovulation was synchronized by daily intramuscular 
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administration of progesterone (150 mg) and estradiol-17ß (10 mg) in oil (Hagyard 
Pharmacy, Lexington, KY, USA) for 10 d [81], with a single intramuscular injection of 
250 µg cloprostenol sodium administered on the 10th day of treatment. BioRelease 
Deslorelin (BET Pharm, Lexington, KY, USA, 1.5 mg) was administered im once a 
preovulatory follicle ≥32 mm diameter and prominent uterine edema were detected. At 
the time of deslorelin administration, mares were assigned in random pairs to be 
inseminated the following day with 1 x 106 sperm by either HYS or TRG. Sperm were 
inseminated in the horn ipsilateral to the dominant follicle. In mares with more than one 
follicle >30 mm, the sperm were placed in the horn ipsilateral to the follicle showing the 
most pronounced preovulatory characteristics (softness on palpation, thickening of the 
follicle lining and loss of circularity on transrectal ultrasonographic examination). Mares 
were inseminated only once, and were examined by transrectal ultrasonography daily 
thereafter to confirm ovulation and at 14 to 16 d post-ovulation for pregnancy 
determination.  
At 14 to 16 days after ovulation, mares were treated with 250 µg, cloprostenol im 
to terminate pregnancy and/or return the mare to estrus. All mares were then allowed a 
minimum of one estrous cycle without treatment. Thirty-three mares were then treated 
again for estrus synchronization as described above. Mare management, semen 
collection and insemination were the same as for the previous replicate except that mares 
were assigned to the opposite treatment group (HYS or TRG), and were inseminated 
with 0.5 x 106 sperm.  
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II.1.2.2. Semen collection  
 Semen was collected as described above in section II.1.1.2. 
II.1.2.3. Semen processing  
Immediately following semen collection, the gel filter was removed from the 
collection bottle to prevent leakage of the gel into the gel-free semen. The gel-free 
semen was transported to an adjacent laboratory and placed in a 37°C incubator. The 
total number of sperm in the ejaculate was determined by measuring the volume of the 
neat semen using a 100-mL graduated cylinder and measuring the concentration using 
the NucleoCounter® SP-100TM. 
An aliquot of neat semen was diluted with pre-warmed (37°C) INRA 96 
containing 1 mg/mL (w:v) ticarcillin disodium and clavulanate potassium (Timentin®; 
GlaxoSmithKline, Research Triangle Park, NC, USA), hereafter referred to as INRA-T, 
to a final concentration of 30 x 106 sperm/mL and a volume of 4.0 mL in a 4-mL 
Cryogenic vial (Corning Life Sciences, Lowell, MA, USA) using the following 
formulas: 
 Volume of raw semen required = (30 x 106 sperm/mL) ÷ (raw semen 
concentration) * (4.0 mL) 
 Volume of extender = (4.0 mL) - (volume of raw semen required) 
One milliliter aliquots of the 30 x 106 sperm/mL extended semen were pipetted into three 
1.2-mL Cryogenic vials. One of these vials was placed directly on a 37°C covered slide 
warmer for 10 minutes prior to evaluation of initial sperm motion characteristics using a 
CASMA. The second and third vials were packaged in a commercial semen-transport 
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container (Equitainer®I; Hamilton Research, Inc., South Hamilton, MA, USA), as 
recommended by the manufacturer with sufficient ballast to control the cooling rate, for 
evaluation of sperm motion characteristics immediately following the deep-horn 
insemination of the final mare of the day and following 24 h of cooled storage (7-8°C). 
A 3:1 extended semen sample was made by adding 1.0 mL of neat semen to a 4-
mL Cryogenic vial containing 3.0 mL of pre-warmed (37°C) INRA-T. The 
concentrations of this 3:1 extended semen sample were measured using the 
NucleoCounter® SP-100TM. 
A 5.0-mL aliquot of either 5 x 106 sperm/mL or 2.5 x 106 sperm/mL was made 
by diluting the appropriate amount of 3:1 extended semen with INRA-T containing 5% 
(v:v) frozen-thawed, sperm-free seminal plasma into 5-mL Cryogenic vials (Corning 
Life Sciences, Lowell, MA, USA). Seminal plasma (SP) was added to the INRA-T to 
ensure that each inseminate contained a minimum of 5% seminal plasma to preserve 
semen quality [75,77,80]. The following formulas were used to produce this semen 
aliquot: 
 volume of sample desired = X + Y 
 X = volume of 3:1 extended semen 
 Y = volume of INRA-T with 5% frozen-thawed, sperm-free seminal 
plasma (v:v) 
 X = (concentration of sample desired) ÷ (concentration of 3:1 extended 
semen) * (volume of sample desired)  
 Y = (volume of sample desired) - X 
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For example, to make 5.0 mL of an inseminate that was 2.5 x 106 sperm/mL from a 3:1 
semen sample that was 75 x 106 sperm/mL: 
 X = (2.5 x 106 sperm/mL) ÷ (75 x 106 sperm/mL) * (5.0 mL) 
 0.167 mL = volume of 3:1 extended semen 
 Y = (5.0 mL) – (0.167 mL) 
 4.833 mL = volume of INRA-T with 5% frozen-thawed, sperm-free 
seminal plasma (v:v) 
Final concentration was evaluated with the NucleoCounter® SP-100TM. The sample was 
adjusted as needed until the concentration reported by the NucleoCounter® SP-100TM 
was within 0.3 x 106 sperm/mL. The vial containing the remaining 3:1 extended semen 
was placed in the Equitainer®I as for the 30 x 106 sperm/mL samples for evaluation 
following 24 h of cooled storage. 
One milliliter aliquots of the 5.0 x 106 sperm/mL or 2.5 x 106 sperm/mL 
extended semen were pipetted into three 1.2-mL Cryogenic vials. The remaining 2 mL 
of extended semen was transferred from the original 5-mL Cryogenic vial to a 2-mL 
Cryogenic vial. One of the 1.2-mL Cryogenic vials was placed immediately on a 37°C 
covered slide warmer for 10 minutes prior to evaluation of initial sperm motion 
characteristics using a CASMA. The 2-mL Cryogenic vial and the remaining two 1.2-
mL Cryogenic vials were packaged in the same Equitainer®I as the 30 x 106 sperm/mL 
samples as described above. The 2-mL Cryogenic vial was stored for deep-horn 
insemination. The 1-mL extended semen samples were stored for evaluation of sperm 
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motion characteristics immediately following the deep-horn insemination of the final 
mare of the day and following 24 h of cooled storage. 
Immediately prior to breeding each mare, a total of 210 µL of semen extended to 
either 5 x 106 sperm/mL or 2.5 x 106 sperm/mL was placed in a 1.5-mL microcentrifuge 
tube for later loading into the appropriate insemination catheter. Losses within the 1.5-
mL microcentrifuge tube were evaluated (data not included) and estimated to be 
approximately 10 µL, thus delivering 200 µL from the catheter during insemination. 
II.1.2.4. Inseminations  
II.1.2.4.1. General insemination protocol 
The mares were restrained and prepared for insemination as described in section 
II.1.1.4.1, except they were sedated with detomidine (4 to 8 mg, iv). 
II.1.2.4.2. Transrectally guided deep-horn insemination (TRG)  
 Transrectally guided deep-horn insemination was performed as described in the 
preliminary study (section II.1.1.4.2) except that loading of the semen into the TRG 
catheter was modified so that the TRG and HYS catheters could be loaded in a similar 
manner. Specifically, the operator donned a sterile sleeve, inserted the distal end of the 
inner catheter into the 1.5-mL microcentrifuge tube, and drew the semen dose into the 
catheter by negative pressure with the syringe which was preloaded with 3 mL of air 
(Figure 8). 
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Figure 8. Aspiration of semen into the distal end of the inner catheter from a 1.5-mL 
microcentrifuge tube. 
 
 
 
 
II.1.2.4.3. Hysteroscopic insemination (HYS)  
 For HYS, semen was held in a 1.5-mL microcentrifuge tube, as described above 
with the TRG technique. The distal end of the inner cannula of an intra-fallopian 
insemination catheter (Cook Veterinary Products®, Spencer, IN, USA) was placed into 
the vial (Figure 9), and the semen was aspirated using a 3-mL syringe preloaded with 2 
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mL of air. The operator donned a sterile sleeve and carried a 1 m flexible video-
endoscope (Olympus GIF Type Q180, Olympus America Inc., Irving, TX, USA) 
transvaginally and passed it through the cervix. The arm was withdrawn from the vagina, 
inserted into the rectum, and the endoscope was guided transrectally to the middle of the 
uterine horn ipsilateral to the dominant follicle (Figure 10), as described by Sieme et al. 
[4]. The proximal end of the uterine horn was compressed around the endoscope, the 
distal uterine horn was insufflated, and the endoscope was advanced until the oviductal 
papilla was visualized. The intra-fallopian insemination catheter was advanced through 
the biopsy channel of the endoscope, then the inner catheter was advanced until it was 
seen to be adjacent to the oviductal papilla, at which time the semen was expelled onto 
the papilla. The syringe was refilled with air and this air was injected through the 
catheter until residual semen could no longer be expelled (Figure 11). The entire catheter 
was drawn back into the endoscope channel, and the endoscope withdrawn to the base of 
the uterine horn. The air was aspirated from the uterine horn only if it was not seen to 
promote semen migration towards the uterine bifurcation. The endoscope and catheter 
were then withdrawn from the mare’s reproductive tract. 
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Figure 9. Aspiration of semen into the distal end of the inner cannula of an intra-fallopian 
insemination catheter (Cook Veterinary Products®, Spencer, IN, USA) from a 1.5-mL 
microcentrifuge tube. 
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Figure 10. The arm was withdrawn from the vagina, inserted into the rectum, and the 
endoscope was guided transrectally to the middle of the uterine horn ipsilateral to the 
dominant follicle. 
 
 
 
 
 
Figure 11. Semen was expelled onto the oviductal papilla. Then, the 3-mL syringe was 
refilled with air and injected through the catheter until residual semen could no longer be 
expelled.  
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II.1.2.5. Cleaning of hysteroscopic equipment  
II.1.2.5.1. Cleaning of the endoscope 
The 1-m flexible video-endoscope used in this study was purchased specifically 
for this study and HYS. It was not exposed to disinfecting agents such as glutaraldehyde 
prior to or during the study, to ensure that no spermicidal residue was present in or on 
the endoscope. The endoscope was, however, cleaned with a combination of high 
pressure air, sterile saline, deionized water, and isopropyl alcohol (70%) before the study 
and after the final deep-horn insemination of each day. Specifically, high pressure air 
was blown through the biopsy channel until fluid was no longer expelled. A clean 4x4 
gauze sponge soaked in sterile saline followed by a dry sponge to wipe off the insertion 
tube and distal head. The suction, air/water, and biopsy valves were removed from their 
respective valve housing within the control body of the endoscope. The valves were 
rinsed with deionized water, then placed in a sterile cup containing isopropyl alcohol 
(70%) until completion of the sterilization process for the rest of the endoscope.  
Aseptic technique was used for the remainder of the cleaning of the endoscope. 
One person held the control body of the endoscope so that the insertion and 
universal/light guide tubes hung vertically. The water-resistant cap was placed on the 
electrical connector, completely sealing the electrical components from water 
contamination. The injection tube was attached to the air pipe, suction connector, and the 
water/air connector. The injection tube intake filter was submerged in a sterile cup 
containing deionized water and a 60-mL syringe was attached to the air/water channel 
port of the injection tube. Deionized water was then injected into the air/water channel, 
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60 mL at time, for a total of 300 – 500 mL. To clean the full length of the air/water 
channel, the endoscope holder plugged the opening to the air/water channel in the 
control body with an index or middle finger, and intermittently allowed some water to 
escape through the opening. This process was repeated with the suction channel except 
that the biopsy channel opening and the suction channel opening in the control body 
both were held closed by the endoscope holder with the right and left index or middle 
fingers. Then, 60 mL of deionized water was injected into the openings of the biopsy, 
suction, and water/air channels in the control body. This entire process of both channels 
and all 3 channel openings was repeated using isopropyl alcohol (70%) to promote 
drying and inhibit bacterial growth. The channels and channel openings were then fully 
dried with high pressure air filtered through a 0.2 µm hydrophobic PTFE filter 
(Millex®-FG Syringe Filter Unit, Hydrophobic PTFE, 50 mm; © EMD Millipore 
Corporation, Billerica, MA, USA). The injection tubes were disconnected and the entire 
outer surface of the endoscope and the injection tubes were thoroughly cleaned with 
sterile 4x4 gauze sponges soaked in deionized water, followed by sponges soaked in 
isopropyl alcohol (70%). The insertion tube of the endoscope was inserted into a sterile 
obstetrical sleeve and then hung from the endoscope rack. The suction, water/air, and 
biopsy valves were placed in a sterile cup to dry overnight.  
The endoscope was not subjected to the above described cleaning and 
sterilization procedures between inseminations within the same day due to practicality 
and the potential spermicidal effects of the deionized water and isopropyl alcohol if not 
given sufficient time to evaporate. Instead, after each insemination, high pressure air was 
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blown through the biopsy channel until fluid was no longer expelled. Then, the insertion 
tube and distal head of the endoscope was aseptically cleaned using a sterile 4x4 gauze 
sponge soaked in 0.9% saline, then dried with a dry, sterile 4x4 gauze sponge. 
II.1.2.5.2. Cleaning of the intra-fallopian insemination catheters 
The intra-fallopian catheter consists of an inner and outer cannula (Figure 12). It 
has a plastic case (Figure 13) that prevents damage to the catheter when not in use. All 
three of these components were individually cleaned/sterilized, re-assembled and 
packaged into a new, clean, gallon storage bag (Ziploc® brand Storage Bags with the 
Smart Zip® Seal; S. C. Johnson & Sons, Inc., Racine, WI, USA).  
 
Figure 12. The inner and outer cannulas of the intra-fallopian insemination catheter (Cook 
Veterinary Products®, Spencer, IN, USA). The inner cannula can be seen coming out of 
the distal end of the outer cannula. 
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Figure 13. The intra-fallopian insemination catheter (Cook Veterinary Products®, 
Spencer, IN, USA) contained within the plastic tubing packaging. 
 
  
 
 
 
The outer plastic case and the inner and outer cannulas were disassembled and 
wiped off with a dry, clean, 4x4 gauze sponge. Using aseptic technique, each component 
was flushed with deionized water, followed by an equal volume of isopropyl alcohol. 
The volume of flush and syringe size used for the outer plastic case, outer cannula, and 
inner cannula were 180-mL/60-mL syringe, 120-mL/20-mL syringe, and 60-mL/12-mL 
syringe, respectively. After each component was flushed, it was placed in a container 
with isopropyl alcohol and allowed to soak until all the catheters and cases used that day 
had been flushed and were in alcohol. Then, in the same order that the catheters had 
been cleaned, they were flushed with high pressure air filtered through a 0.2 µm 
hydrophobic PTFE filter to remove all remaining alcohol from the lumen, and their outer 
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surfaces were dried with sterile 4x4 gauze sponges. The catheters were then reassembled 
and inserted into their plastic case as described above. 
II.1.3. Seminal plasma (SP) processing 
Two ejaculates were collected from the same stallion used in the experiments to 
obtain sperm-free seminal plasma. Semen was collected as described in section II.1.1.2. 
Following semen collection, the semen was placed into two 15-mL polypropylene 
conical-bottom tubes (Corning Life Sciences, Lowell, MA, USA), and centrifuged at 
2000 x g for 10 min (IEC Centra CL2; Thermo Scientific, Waltham, MA, USA). The 
seminal plasma was decanted into 20-mL all-plastic syringes (2-part disposable syringes 
HSW Norm-Ject®; Henke Sass Wolf, Tuttlingen, Germany) fitted with tandem 5.0 µm 
and 1.2 µm nylon filters (Cameo 30N Syringe Filter, Nylon, 30 mm; Sigma-Aldrich, St. 
Louis, MO, USA). The seminal plasma was passed through the filters into a 50-mL 
conical vial (Corning Life Sciences, Lowell, MA, USA) to remove any remaining sperm. 
Aliquots (1 mL) of seminal plasma were stored in 1.5-mL snap-cap microcentrifuge 
tubes (disposable/conical economy micro tubes with snap caps; VWR International, 
USA) which were frozen and stored in a freezer at -80°C until used. 
II.1.4. Measurement of sperm concentration  
A NucleoCounter® SP-100TM (ChemoMetec A/S, Allerød, Denmark) was used 
for all semen concentration measurements. It utilizes a proprietary reagent, Reagent S-
100 (ChemoMetec A/S, Allerød, Denmark) to permeabilize the sperm plasma 
membranes and propidium-iodide to label the DNA in the permeabilized spermatozoa. 
The dilution factors used in these experiments were 1:100 for raw semen and for 3:1 
 49 
 
extended semen (10 µL of semen to 1.0 mL of Reagent S-100), and 1:10 for 2.5 x 106 
and 5.0 x 106 sperm/mL (100 µL of semen to 1.0 mL of Reagent S-100). 
To prepare the dilutions, each semen sample was thoroughly mixed and the 
appropriate volume of semen was drawn up into a positive displacement pipette (10 µL 
with a 1-10-µL pipette; 100 µL with a 10-100-µL pipette). The sides of the pipette tip 
were wiped with a delicate task wiper (Kimtech ScienceTM Kimwipes®, Kimberly-Clark 
ProfessionalTM, Roswell, GA, USA) to remove excess semen. The semen was dispensed 
into the 1.2-mL Cryogenic vial preloaded with 1.0 mL of Reagent S-100. The vial was 
inverted a minimum of 10-15 times to thoroughly mix its contents. The tip of the SP-1 
Cassette (ChemoMetec A/S, Allerød, Denmark) was immersed into the reagent-semen 
solution, the cassette piston depressed, pulling the appropriate amount of solution into 
the cassette. The cassette was inserted into the NucleoCounter® and the total sperm/mL 
was measured. 
II.1.5. Evaluation of sperm motion characteristics (sperm motility) 
Because the inseminations for each insemination dose did not occur on the same 
day, sperm motility characteristics were evaluated to ensure that mares included in the 
analysis of pregnancy rates were being inseminated with similar quality semen. All 
semen samples were evaluated using computer-assisted motion analyzer (CASMA; 
IVOS version 12.2L; Hamilton Thorne Biosciences, Beverly, MA, USA) following 10 
minutes of warming at 37°C on a covered slide warmer. The extended semen was 
thoroughly mixed then 6 µL of the semen was loaded into a warmed (37°C) disposable 
counting chamber (Leja 20 um, 2 chamber slide; Leja Products B.V., Nieuw-Vennep, 
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The Netherlands). The slide was placed onto a warmed stage and inserted into the 
CASMA. For the 30 x 106 sperm/mL samples, a minimum of 10 microscopic fields and 
500 sperm cells were analyzed per sample. For the 5.0 x 106 and 2.5 x 106 sperm/mL, all 
microscopic fields on a slide were analyzed to compensate for the low sperm 
concentration in the samples. The preset values for the IVOS system were as follows: 
frames acquired – 45; frame rate – 60 Hz; minimum contrast – 70; minimum cell size – 4 
pixels; minimum static contrast – 30; straightness (STR) threshold for progressive 
motility – 50; average-path velocity (VAP) threshold for progressive motility – 30; VAP 
threshold for static cells – 15; cell intensity – 106; static head size – 0.60 to 2.00; static 
head intensity – 0.20 to 2.01; static elongation – 40 to 85; LED illumination intensity – 
2200. Experimental endpoints for these studies were total sperm motility (TMOT), 
progressive sperm motility (PMOT, %), curvilinear velocity (VCL, µ/s), average-path 
velocity (VAP, µ/s), straight-line velocity (VSL, µ/s), and straightness (STR, %). 
II.1.6. Statistical analysis 
II.1.6.1. Pregnancy rates  
Pregnancy rates between groups were compared using Chi-square analysis. 
Fisher’s exact test was used when a value of less than 5 was expected for any square. For 
all analyses, P < 0.05 was considered significantly different. 
II.1.6.2. Sperm motion characteristics (sperm motility)  
A mixed model analysis of variance (SAS Institute, Cary, NC) was used to 
determine differences in treatment (sperm concentration). Parameters expressed as a 
percentage (TMOT, PMOT, and STR) were arcsin square root transformed to normalize 
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the data prior to analysis. The effects of stallion, ejaculate and ejaculate within stallion 
were considered random. 
II.2. Results 
II.2.1. Preliminary study  
 Twenty-eight mares were inseminated utilizing either TRG or conventional 
uterine body insemination for a total of 44 estrous cycles. Conventional uterine body 
insemination (≥1 x 109 progressively motile sperm) was used on 18 cycles; whereas, 
TRG was used on 14 and 12 cycles for 1 x 106 and 0.5 x 106 total sperm, respectively. 
Exact day of ovulation was determined for 40 cycles. The four cycles with unconfirmed 
days of ovulation (2 – 0.5 x 106 TRG; 2 – 1 x 106 TRG) were in mares bred on Friday 
that could not be examined over the weekend due to inaccessibility to the mares. All four 
had a prominent corpus luteum the following Monday. In these four mares, the two 
mares that received an ovulatory induction agent the day before breeding (1 – 0.5 x 106; 
1 – 1 x 106) were pregnant while the two mares that received the ovulatory induction 
agent the day of insemination (1 – 0.5 x 106; 1 – 1 x 106) were not pregnant. 
 In the 40 cycles for which the exact day of ovulation was determined (based on 
daily transrectal ultrasonographic examinations starting the day the mares were treated 
with an ovulatory induction agent), ovulation occurred the same day as insemination (n 
= 1), and within 24 (n = 30), 48 (n = 8), and 96 (n = 1) hours of insemination. Mares 
bred with conventional uterine body insemination ovulated within 24 h (n = 13) and 48 h 
(n =5) of insemination. All but 3 of these mares were pregnant; the three non-pregnant 
mares ovulated within 24 h of insemination. Mares inseminated with 1.0 x 106 sperm 
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ovulated within 24 (n = 9), 48 (n = 2), and 96 (n = 1) of insemination. A total of 5 
pregnancies resulted, all from breedings that occurred within 24 h of insemination. 
Mares inseminated with 0.5 x 106 sperm ovulated within 0 (n = 1), 24 (n = 8), and 48 (n 
= 1) hours of insemination. Two mares were pregnant; these mares ovulated within 24 or 
48 h of ovulation.  
Pregnancy rates were higher for conventional uterine body insemination (UBI) 
than for TRG with 1 x 106 sperm (15/18, 83% vs. 6/14, 43%, respectively; P = 0.03) and 
with 0.5 x 106 sperm (15/18, 83% vs. 3 /12, 25%, respectively; P = 0.002) (Table 1). 
Pregnancy rates were not different between TRG insemination doses (6/14, 43% vs. 
3/12, 25%, respectively; P = 0.4) (Table 1).  
 
Table 1. Pregnancy rates relative to time of ovulation (n = 44) for mares bred with 
conventional uterine body insemination (UBI) using ≥1 billion progressively motile 
sperm or with TRG using either 1 or 0.5 x 106 sperm from one Quarter Horse stallion. 
 
Day of Ovulation 
Relative to 
Insemination (hrs) 
Insemination Dose & Method 
≥1 x 109 – UBI 1 x 106 – TRG 0.5 x 106 – TRG 
0 -- -- 0 / 1 (0%) 
≤24 10 / 13 (85%)a 5 / 9 (56%)ac 1 / 8 (13%)bc 
≤48 5 / 5 (100%)a 0 / 2 (0%)bc 1 / 1 (100%)ac 
≤96 -- 0 / 1 (0%) -- 
Unknown* -- 1 / 2 (50%)a 1 / 2 (50%)a 
Total 15/18 (83%)a 6 / 14 (43%)b 3 / 12 (25%)b 
* Unknown = mares bred on a Friday and next examination was Monday 
abc Within rows, rates with different superscripts differed (P < 0.05) 
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II.2.2. Main study  
II.2.2.1. Pregnancy rates  
Of the 37 mares that started this experiment, nine were eliminated due to 
development of hemorrhagic anovulatory follicles (n = 3), failure to ovulate within 72 h 
after insemination (n = 2), presence of excessive endometrial cysts (n = 1), excessive 
intrauterine fluid accumulation after breeding (n = 2), or presence of hyperechoic 
intrauterine fluid at the end of the second estrus synchronization (n = 1). This resulted in 
28 mares that were inseminated using both techniques (Table 2). All 28 mares 
inseminated with 1 x 106 sperm and 26/28 mares inseminated with 0.5 x106 sperm 
ovulated with 24 h of insemination. The remaining 2 mares inseminated with 0.5 x 106 
sperm ovulated within 48 h of insemination; both were bred by HYS and neither was 
pregnant. There was no significant difference in pregnancy rates between HYS and TRG 
methods when mares were inseminated with 1 x 106 sperm (HYS 10/13, 77% vs TRG 
11/15, 73%; P = 1) or with 0.5 x 106 sperm (HYS 3/15, 20% vs TRG 4/13, 31%; P = 
0.7). Pregnancy rates were not different between insemination techniques when the 
insemination doses of 0.5 or 1 x 106 sperm were combined (HYS 13/28, 46% vs TRG 
15/28, 54%; P = 0.8). Pregnancy rates were higher in mares inseminated with 1 x 106 
sperm than in mares inseminated with 0.5 x 106 sperm (21/28, 75% vs. 7/28, 25%, 
respectively; P < 0.01). This difference in pregnancy rates between sperm doses held 
true even when mares that ovulated more than 24 h after insemination were excluded 
(21/28, 75% vs. 7/26, 27%, respectively; P < 0.001). 
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Table 2. Pregnancy rates in mares (n = 28) inseminated hysteroscopically (HYS) or 
transrectally (TRG) with either 1.0 or 0.5 x 106 sperm from one Quarter Horse stallion. 
 
Insemination 
Method 
Number of Sperm Inseminated 
1 x 106 0.5 x 106 Combined 1 and 0.5 x 106 
HYS 10/13 (77%)a 3/15 (20%)b 13/28 (46%) 
TRG 11/15 (73%)a 4/13 (31%)b 15/28 (54%) 
Total 21/28 (75%)a 7/28 (25%)b  
ab  Within adjacent columns, rates without a common subscript differed (P < 0.05). 
 
 
 
II.2.2.2. Sperm motion characteristics (sperm motility) 
To ensure that mares included in the analysis of pregnancy rates were being 
inseminated with similar quality semen, sperm motion characteristics were evaluated on 
every ejaculate at the time of collection (T0), following insemination of all mares for the 
day (T-End), and following 24 h of cooled storage (T24) at 7-8°C. The TMOT and 
PMOT for T0 and T-End for each ejaculate included in the pregnancy rate data are 
included in Table 3-4. Because difference in sperm quality often become more evident 
following storage, the mean and standard error the mean (± SEM) were calculated for 
TMOT, PMOT, VCL, VAP, VSL, and STR for the ejaculates at T24 (Table 5). The 3:1 
samples had a mean sperm concentration of 55 x 106/mL (range = 23 to 138 x 106/mL).  
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Table 3. Total and progressive motility at the time of semen collection (T0) and following insemination of all mares for the day 
(T-End) for the ejaculates used for the 1.0 x 106 insemination dose. 
 
Ejaculate 
Semen Samples 
T0 / 30 x 106* T-End / 30 x 106* T-End / 5 x 106* 
TMOT§ PMOT§ TMOT§ PMOT§ TMOT§ PMOT§ 
1 97 77 -- -- 92 84 
2 95 69 89 74 77 71 
3 92 70 88 70 85 76 
4 96 78 89 71 77 66 
5 95 68 89 64 83 65 
6 91 67 91 67 81 64 
7 94 70 94 70 83 73 
8 95 74 94 79 91 87 
9 96 74 96 74 91 87 
10 97 74 96 72 91 73 
Mean (Range) 95 (91-97) 72 (67-78) 92 (88-96) 71(64-79) 85 (77-92) 75 (64-87) 
§ TMOT = total sperm motility (%) 
 PMOT = progressive sperm motility (%) 
* T0 / 30 x 106 = 30 x 106 sperm/mL at the time of semen collection 
 T-End / 30 x 106 = 30 x 106 sperm/mL following insemination of all mares for the day 
 T-End / 5 x 106 = 5 x 106 sperm/mL following insemination of all mares for the day 
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Table 4. Total and progressive motility at the time of semen collection (T0) and following insemination of all mares for the day 
(T-End) for the ejaculates used for the 0.5 x 106 insemination dose. 
 
Ejaculate 
Semen Samples 
T0 / 30 x 106* T-End / 30 x 106* T-End / 2.5 x 106* 
TMOT§ PMOT§ TMOT§ PMOT§ TMOT§ PMOT§ 
1 96 77 92 82 84 80 
2 95 68 89 72 69 61 
3 96 75 92 79 79 73 
4 97 79 88 74 73 70 
5 91 61 86 65 81 75 
6 90 67 88 70 70 63 
7 94 75 91 77 87 75 
Mean (Range) 94 (90-97) 72 (61-79) 89 (86-92) 74 (65-79) 78 (69-87) 71 (61-80) 
§ TMOT = total sperm motility (%) 
 PMOT = progressive sperm motility (%) 
* T0 / 30 x 106 = 30 x 106 sperm/mL at the time of semen collection 
 T-End / 30 x 106 = 30 x 106 sperm/mL following insemination of all mares for the day 
 T-End / 2.5 x 106 = 2.5 x 106 sperm/mL following insemination of all mares for the day 
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The TMOT for the 1.0 x 106 insemination dose at T0 (30 x 106), T-End at 30 x 
106 sperm/mL, and T-End at 5 x 106 sperm/mL had means of 95% (range 91 to 97%), 
92% (range 88 to 96%), and 85% (range 77 to 92%), respectively. The PMOT for the 1.0 
x 106 insemination dose at T0, T-End at 30 x 106 sperm/mL, and T-End at 5 x 106 
sperm/mL had means of 72% (range 67 to 78%), 71% (range 64 to 79%), and 75% 
(range 64-87%), respectively. The TMOT for the 0.5 x 106 insemination dose at T0, T-
End at 30 x 106 sperm/mL, and T-End at 2.5 x 106 sperm/mL had means of 94% (range 
90 to 97%), 89% (range 86 to 92%), and 78% (range 69-87%), respectively. The PMOT 
for the 0.5 x 106 insemination dose at T0, T-End at 30 x 106 sperm/mL, and T-End at 2.5 
x 106 sperm/mL means of 71% (range 61 to 79%), 74% (range 65 to 79%), and 71% 
(range 61-80%), respectively.  
 
 
Table 5. Sperm motion characteristics following 24 h of cooled storage (T24) in an 
Equitainer®I (mean ± SEM).  
 
Motility 
Parameter§ 
Semen Samples 
2.5 x 106* 5 x 106* 30 x 106* 3:1SD* 
TMOT 83 (2)b 85 (2)b 90 (1)a 87 (2)ab 
PMOT 68 (2)a 66 (3)a 57 (3)ab 52 (3)b 
VCL 212 (7)ab 204 (9)b 225 (6)a 220 (8)ab 
VAP 103 (4)b 102 (5)b 114 (3)a 114 (4)a 
VSL 76 (2)a 72 (2)a 72 (2)a 73 (3)a 
STR 75 (2)a 73 (3)a 62 (2)b 62 (1)b 
§ TMOT = total sperm motility (%); PMOT = progressive sperm motility (%); 
 VCL = curvilinear velocity (µm/s); VAP = average-path velocity (µm/s); 
 VSL = straight-line velocity (µm/s); STR = straightness ([VSL/VAP]100; %) 
* 2.5 x 106 = 2.5 x 106 sperm/mL (n = 7) 
 5 x 106 = 5 x 106 sperm/mL (n = 10) 
 30 x 106 = 30 x 106 sperm/mL (n = 17) 
 3:1SD = 3:1 Simple Dilution (n = 17) 
ab Within rows, rates with different superscripts differed (P < 0.05) 
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At T24 (Table 5), the TMOT was higher than 2.5 x106 and 5 x 106 (P < 0.05) but, 
similar to 3:1SD; and 3:1SD was similar to 2.5 x 106 and 5 x 106. The PMOT for 2.5 
x106 and 5 x 106 was higher than 3:1SD (P < 0.05); and 30 x 106 was similar to 2.5 x 106 
and 5 x 106. The VCL for 30 x 106 was higher than 5 x 106 (P < 0.05); and similar to 2.5 
x 106 and 3:1SD (P < 0.05). The VAP for 30 x 106 and 3:1SD were higher than 2.5 x 106 
and 5 x 106 (P < 0.05). The VSL was similar among all treatments (P ≥ 0.05). STR at 2.5 
x 106 and 5 x 106 were higher than 30 x 106 and 3:1SD (P < 0.05). 
II.3. Discussion  
Low-dose deep-horn insemination is commonly used in equine practice because 
it is believed that delivering a small volume of relatively concentrated semen closer to 
the site of fertilization (tip of the uterine horn ipsilateral to the site of ovulation) may 
improve fertility [1]. Fertility trials involving horses commonly utilize an insemination 
dose of 250 to 500 x 106 progressively motile sperm for uterine body insemination, 
which should provide optimum pregnancy rates, regardless of inter-stallion variability. 
However, using supra-threshold sperm numbers can mask the ability of the experimental 
design to detect a difference in technique (i.e. HYS vs. TRG) due to excess sperm 
numbers. In the present study, we performed a preliminary trial to establish a sperm 
insemination number that was below the threshold for optimal fertility for the stallion in 
this study. The results of the preliminary trial indicated that for this stallion deep-horn 
insemination of either 1 or 0.5 x 106 sperm resulted in pregnancy rates (43 and 25%, 
respectively) that were lower than if more sperm (≥1 x 109) were inseminated into the 
uterine body (83%). Establishing a “subthreshold” sperm level allowed us to evaluate 
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whether one technique (HYS or TRG) would provide higher pregnancy rates than the 
other.  
In our main experiment, the efficacy of HYS and TRG techniques were similar; 
this finding agrees with previous studies utilizing 5 x 106 total, cool-stored sperm [46] 
and 20 x 106 sex-sorted sperm [18]. However, in contrast to the preliminary experiment, 
in this experiment only the 0.5 x 106 insemination dose appeared to be below the 
threshold number required to achieve normal pregnancy rates. Thus, mares were 
inseminated with a subthreshold insemination dose using only one of the deep-horn 
insemination techniques, preventing the complete removal of mare variability. But, 
because all mares in this experiment were proven, fertile mares, the similarity in 
pregnancy rates between HYS and TRG achieved with 0.5 x 106 sperm confirmed that 
these two techniques can be expected to achieve similar efficacy when below-threshold 
levels of sperm are inseminated. These results, therefore, contradict the recommendation 
of Squires [47] to utilize HYS when sperm numbers in the inseminate are less than 25 to 
50 x 106. This finding also suggests that there is a subthreshold level of sperm, even in 
fertile stallions, that cannot be overcome by using the deep-horn technique. Therefore, 
there are clinical circumstances (e.g. stallions with inherently poor semen quality or 
frozen semen from some stallions) under which it cannot be assumed that either 
technique will improve fertility. 
It is unclear why pregnancy rates with TRG insemination of 1 x 106 sperm were 
higher in the main experiment than they were in the preliminary trial. Improvements in 
pregnancy outcome did, however, occur as the operator gained more expertise in the 
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TRG technique. In addition, they may have been due to administration of detomidine 
prior to insemination, since mares bred in the preliminary trial were not tranquilized as 
opposed to the mares in the main study. Detomidine is an α2-adrenergic receptor agonist 
that increases uterine contractions in the normal non-pregnant mare [82]; there initially 
was concern that it might interfere with uterine contractions necessary to propel sperm 
toward the oviduct, or cause premature evacuation of sperm from the uterus. However, 
the normal pregnancy rates (73 to 77%) achieved with insemination of 1 x 106 sperm 
using either technique in this study, as well as the good pregnancy rates achieved in 
previous studies [46], suggested that detomidine administration prior to deep-horn 
insemination was not detrimental. Likewise, tranquilization of maiden mares prior to 
natural service did not reduce pregnancy rates [83]. Due to its ability to reduce rectal 
peristalsis and tone, detomidine may allow a more accurate and consistent placement of 
the intrauterine catheter at the tip of the uterine horn and it may facilitate the operator’s 
ability to orient the tip of the uterine horn ventrally. We postulate that the ventral 
orientation of the uterine horn tip may promote pooling of the inseminate on or around 
the oviductal papilla. The value of holding the tip of the uterine horn ventrally, however, 
has not been critically evaluated. 
From these findings, we conclude that whereas high fertility can be achieved 
with very low sperm numbers, there is a functional threshold below which fertility 
cannot be improved through deep-horn insemination techniques alone, even in a fertile 
stallion. Previous workers were not able to increase fertility in a subfertile stallion using 
TRG insemination of 25 x 106 sperm (29% pregnancy rate) compared to that achieved 
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with a fertile stallion with good semen quality (63% pregnancy rate) [45]. Sperm quality 
(DNA quality, sperm morphology and motility) can be selected for by centrifugation 
through density gradients [84-87], which aids in removal of sperm with abnormal heads 
and midpieces, bent midpieces, bent tails, coiled tails and premature germ cells [84]. 
Low-dose deep-horn insemination of these purified samples may increase fertility in 
some circumstances [10-12,14].  
Use of the hysteroscope may [4,34] or may not [4,9] increase the chance of 
endometritis. Schiemann et al. [34] reported histopathologic evidence of endometritis in 
all eight mares subjected to diagnostic hysteroscopy, and bacterial pathogens were 
isolated in 6/8 mares. Hysteroscope-derived post-insemination endometritis was not 
reported in one study following repeated inseminations [9]. Sieme et al. [4] reported no 
clinical effect of hysteroscopy in reproductively normal mares, but pregnancy rates were 
lower for HYS of fresh semen compared to standard uterine body insemination in 
subfertile mares, suggesting that mares susceptible to infection may be at greater risk 
with the HYS technique. Nie et al. [88] found that post-breeding endometritis was lower 
following the TRG technique compared to conventional uterine body insemination, 
whereas Güvenc et al. [35] found no difference in post-breeding endometritis following 
the same two techniques. 
Despite routine sterilization between procedures, endoscopes used for human 
applications have been identified as a source for the biofilm-producing bacteria 
Escherichia coli and Pseudomonas aeruginosa, resulting in nosocomial infections [27-
31]. These bacteria are known pathogens of the equine endometrium [89,90]. They were 
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isolated from 6 of 8 mares following diagnostic hysteroscopy in one study [34] and have 
been associated with reduced pregnancy rates in mares [89]. In contrast, the catheter 
used for TRG is inexpensive and a new catheter may be used for each mare, eliminating 
the possibility of nosocomial infection.  
 In summary, similar pregnancy rates were achieved with low-dose insemination 
using a subthreshold number of sperm when either hysteroscopically guided or 
transrectally guided techniques were used. Due to simplicity, lower cost, reduction of 
time involved, and reduction of the possibility of nosocomial infections, the transrectally 
guided technique may be the method of choice for low dose insemination in the mare. 
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CHAPTER III 
EFFECT OF DILUTION AND SEMINAL PLASMA ON MOTION 
CHARACTERISTICS AND PLASMA MEMBRANE INTEGRITY 
OF STALLION SPERM 
 
III.1. Materials and Methods 
A study was conducted to evaluate the sperm motion characteristics and plasma 
membrane integrity of stallion semen when processed to 2.5 x 106 sperm/mL as used for 
low-dose insemination. Three ejaculates were collected from each of three stallions, two 
20-yr old American Quarter Horses and a 9-yr old American Paint Horse, for a total of 9 
ejaculates. The study was conducted in September 2009 in southeast Texas. All 
experimental procedures were performed according to the United States Government 
Principles for Utilization and Care of Vertebrate Animals Used in Testing, Research and 
Training and were approved by the Laboratory Animal Care Committee at Texas A&M 
University. 
III.1.1. Semen collection  
An ejaculate was collected daily as described in section II.1.1.2 from each of 3 
stallions for 3 consecutive days, for a total of 9 ejaculates (3 ejaculates/stallion). 
III.1.2. Semen processing  
Immediately following semen collection, the gel filter was removed from the 
collection bottle to prevent leakage of the gel into the gel-free semen. The gel-free 
semen was placed in a 37°C incubator. The total number of sperm in the ejaculate was 
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determined by measuring the volume of the neat semen using a 10- mL graduated 
cylinder and measuring the concentration using the NucleoCounter® SP-100TM as 
detailed in Chapter II. 
Using pre-warmed (37°C) INRA-T and neat semen, a 3:1 extended semen 
sample (3:1SD) and a 30 x 106 sperm/mL sample (30) were made. The 3:1SD sample 
was made by adding 1.5 mL of neat semen into a 15-mL conical vial containing 4.5 mL 
INRA-T. A 5.0-mL semen sample with a concentration of 30 x 106 sperm/mL (30) was 
made using the following formula and placed into a 5.0-mL Cryogenic vial: 
 Volume of raw semen required = (30 x 106 sperm/mL) ÷ (raw semen 
concentration) * (5.0 mL) 
 Volume of extender = (5.0 mL) - (volume of raw semen required) 
The total sperm and non-plasma membrane-intact sperm concentrations were determined 
for both semen samples using the NucleoCounter® SP-100TM as described below in 
Section III.1.4. Aliquots for evaluation of initial sperm motion characteristics were made 
by pipetting 0.5 mL of the 3:1SD and 30 preparations into 0.5-mL Eppendorf tubes. The 
aliquots were then placed on a 37°C covered slide warmer for 10 minutes prior to 
evaluation. Two 1.2-mL aliquots were placed in separate 1.2-mL Cryogenic vials for 
evaluation following 24- and 48-h of cooled storage (7-8°C) in an Equitainer®I. 
Five-milliliter semen samples with a concentration of 2.5 x 106 sperm/mL were 
made by diluting the appropriate amount of 3:1 extended semen with INRA-T, INRA-T 
with 7.5% frozen-thawed, sperm-free seminal plasma (v:v), or INRA-T with 25% 
frozen-thawed, sperm-free seminal plasma (v:v); thus, a total of 3 samples were made at 
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2.5 x 106 sperm/mL. These 2.5 x 106 sperm/mL treatments extended with 0, 7.5 and 25% 
seminal were designated as 2.5/0, 2.5/7.5, and 2.5/25. The following formulas were used 
to produce these semen samples: 
 volume of sample desired = X + Y 
 X = volume of 3:1 extended semen 
 Y = volume of semen extender 
 X = (2.5 x 106 sperm/mL) ÷ (concentration of 3:1 extended semen) * (5.0 
mL)  
 Y = (5.0 mL) - X 
The total sperm and non-plasma membrane-intact sperm concentrations were determined 
for all 2.5 x 106 sperm/mL semen samples using the NucleoCounter® SP-100TM. A 0.5-
mL aliquot of each of the 2.5 x 106 sperm/mL samples was pipetted into a 0.5-mL 
Eppendorf tube, then placed on a 37°C covered slide warmer for 10 minutes prior to 
evaluation of initial sperm motion characteristics using a CASMA. Two 1.2-mL aliquots 
of each of the 2.5/25 samples were pipetted into separate 1.2-mL Cryogenic vials for 
evaluation following 24 and 48 h of cool storage (7-8°C) in an Equitainer®I. 
Two Equitainers per stallion were used for the 24- and 48-h cooled storage 
samples to ensure that cooling was not disturbed when the 24-h samples were evaluated. 
Semen samples were packaged as recommended by the manufacturer with sufficient 
ballast to control the cooling rate. In addition to the above-described semen samples, a 2-
mL Cryogenic vial containing 2 mL of INRA-T with 25% frozen-thawed, sperm-free 
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seminal plasma (v:v) was placed into each of the Equitainers. This extender was used to 
make a 30 x 106 sperm/mL aliquot of the 3:1SD for motility analysis. 
Following 24 and 48 h of cool storage, 0.5-mL aliquots of all semen samples 
were pipetted into 0.5-mL Eppendorf tubes for analysis. When the concentration of the 
3:1SD sample was greater than 30 x 106 sperm/mL, a 0.5-mL aliquot was made by 
diluting the appropriate amount of the sample with INRA-T containing 25% frozen-
thawed seminal plasma (v:v) to a concentration of 30 x 106 sperm/mL (3:1/30) using the 
following formulas:  
 Volume of 3:1 extended semen required = (30 x 106 sperm/mL) ÷ (3:1 
extended semen sperm concentration) * (0.5 mL) 
 Volume of extender = (0.5 mL) - (volume of 3:1 extended semen required) 
All of these 0.5-mL aliquots were placed on a 37°C covered slide warmer for 10 minutes 
prior to evaluation of sperm motion characteristics using a CASMA. The semen 
remaining in each of the original 1.2-mL Cryogenic vials were evaluated for total sperm 
and non-plasma membrane-intact sperm concentrations using the NucleoCounter® SP-
100TM. 
III.1.3. Seminal plasma (SP) processing  
Prior to the experiment, one ejaculate was collected from each of the 3 stallions 
used in the experiment to obtain sperm-free seminal plasma. Semen was collected as 
described in section II.1.1.2 and processed as described in section II.1.3 to collect 
seminal plasma, which was then frozen and stored in a -80°C freezer, as described in 
section II.1.3, until used. 
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III.1.4. Evaluation of sperm concentration and plasma membrane integrity  
The NucleoCounter® SP-100TM was the system used for determination of total 
sperm and non-plasma membrane-intact sperm concentrations. As described in section 
II.1.4, Reagent S-100 was used for measurement of total sperm concentration because it 
permeabilizes the plasma membrane, allowing propidium-iodide to label the DNA of all 
spermatozoa in the sample. To evaluate the concentration of the non-plasma membrane-
intact sperm, phosphate-buffered saline (PBS, GIBCO® Dulbecco’s Phosphate Buffered 
Saline 1X; Invitrogen; Grand Island, NY, USA) was substituted for the Reagent S-100. 
The dilution factors (DF) used in this experiment were prepared according to the 
following table (Table 6). 
 
Table 6. NucleoCounter® SP-100TM dilution factors used in the evaluation of plasma 
membrane integrity. 
 
Sperm 
Concentration 
(x 106/mL) Dilution Factor 
Diluent Volume 
(µL) 
Semen Volume 
(µL) 
<2.5 6 500 100 
2.5-30  11 1000 100 
30-180 101 1000 10 
180-300 201 2000 10 
 
 
Each semen sample was thoroughly mixed and the appropriate volume of semen 
was drawn up into a positive-displacement pipette (10 µL with a 1 – 10 µL pipette; 100 
µL with a 10 – 100 µL pipette). The sides of the pipette tip were wiped with a Kimwipe 
to remove excess semen. The semen was dispensed into the 1.2- or 2.0-mL Cryogenic 
vial preloaded with the appropriate amount of Reagent S-100 or PBS. The vial was 
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inverted a minimum of 10-15 times to thoroughly mix its contents. The tip of the SP-1 
Cassette (ChemoMetec A/S, Allerød, Denmark) was immersed into the reagent-semen 
solution, the cassette piston depressed, pulling the appropriate amount of solution into 
the cassette. The cassette was inserted into the instrument and the total sperm/mL was 
measured. The total sperm concentration for each semen sample was evaluated prior to 
evaluation of the non-plasma membrane-intact sperm to allow the SemenViewTM 
program (Version 1.21; ChemoMetec A/S, Allerød, Denmark) to calculate the 
percentage of plasma membrane-intact sperm. If an error occurred in the order that the 
tests were run, the percentage of plasma membrane-intact sperm was calculated by hand 
using the following equation: 
 % of plasma membrane-intact spermatozoa = [(total sperm concentration) – 
(non-plasma membrane-intact sperm concentration)] ÷ (total sperm 
concentration) * 100% 
III.1.5. Evaluation of sperm motion characteristics (sperm motility) 
Sperm motion characteristics were evaluated as described in section II.1.5 using 
a CASMA. A minimum of 10 microscopic fields and 500 sperm cells were analyzed in 
the 30, 3:1SD and 3:1/30 samples. The range of the concentration of the 3:1 non-
adjusted samples was 23 to 75 x 106 sperm/mL. For the 2.5/25 samples, all microscopic 
fields on a slide were analyzed to compensate for the low sperm concentration. 
Experimental endpoints for this study were total sperm motility (TMOT), progressive 
sperm motility (PMOT), curvilinear velocity (VCL), average-path velocity (VAP), 
straight-line velocity (VSL), and straightness (STR). 
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III.1.6. Statistical analysis 
A mixed model analysis of variance (SAS Institute, Cary, NC) was used to 
determine differences due to treatment (sperm concentration). Parameters expressed as a 
percentage (TMOT, PMOT, PMI, and STR) were arcsin square root transformed to 
normalize the data prior to analysis. The effects of stallion, ejaculate and ejaculate within 
stallion were considered random. 
III.2. Results 
A total of nine ejaculates was analyzed for each treatment except for the 3:1/30 
which only included 7 samples because the 3:1SD were ≤30 x 106 sperm/mL in two 
samples; the concentration of the 3:1SD samples ranged from 23 to 75 x 106 sperm/mL 
(50 x 106 ± 3, mean ± SEM). The seminal plasma concentration in the 30 treatments 
ranged from 11 to 32% (mean, 18%). The final seminal plasma concentration in the 
2.5/0, 2.5/7.5 and 2.5/25 treatments were 0.9-2.6%, 8.4-10.1%, 25.9-27.6%, 
respectively. 
At T0 (Table 7), the PMI and TMOT were higher in 30 and 3:1SD than all 2.5 x 
106 sperm/mL treatments (P < 0.05). The PMOT for 30 and 3:1SD were higher than 
2.5/7.5 and 2.5/25 (P < 0.05), but similar to 2.5/0 (P ≥ 0.05). In general for VCL, VAP, 
and VSL, velocities were higher in those treatments with higher seminal plasma 
concentration (i.e. >11%; 2.5/25, 30, 3:1SD) compared to 2.5/0 and 2.5/7.5 (P < 0.05). 
The STR was higher in the 2.5/0 than all the other treatments (P < 0.05). 
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Table 7. Initial sperm motion characteristics and sperm plasma membrane integrity for 9 
ejaculates (3 ejaculates per stallion) (mean ± SEM). 
 
Laboratory 
Parameter§ 
Semen Samples 
2.5/0* 2.5/7.5* 2.5/25* 30* 3:1SD* 
PMI 78 (3)b 76 (5)b 75 (4)b 81 (5)a 82 (4)a 
TMOT 71 (5)b 77 (5)b 73 (4)b 87 (4)a 90 (3)a 
PMOT 55 (6)ab 50 (7)bc 47 (6)c 59 (6)a 62 (5)a 
VCL 213 (5)c 226 (11)bc 248 (10)a 241 (6)ab 230 (9)abc 
VAP 104 (2)c 121 (3)b 131 (3)a 127 (4)ab 124 (6) ab 
VSL 77 (4.6)b 81 (5.0)ab 85 (5.0)a 87 (4.7)a 85 (5.9)a 
STR 74 (4)a 67 (3)b 64 (3)b 66 (2)b 66 (2)b 
§ PMI = plasma membranes intact sperm (%) 
 TMOT = total sperm motility (%); PMOT = progressive sperm motility (%); 
 VCL = curvilinear velocity (µm/s); VAP = average-path velocity (µm/s); 
 VSL = straight-line velocity (µm/s); STR = straightness ([VSL/VAP]100; %) 
* 2.5/0 = 2.5 x 106 sperm/mL with 0% seminal plasma added (n = 9) 
 2.5/7.5 = 2.5 x 106 sperm/mL with 7.5% seminal plasma added (n = 9) 
 2.5/25 = 2.5 x 106 sperm/mL with 25% seminal plasma added (n = 9) 
 30 = 30 x 106 sperm/mL (n = 9) 
 3:1SD = 3:1 Simple Dilution (n = 9) 
abc Within rows, rates with different superscripts differed (P < 0.05) 
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Table 8. Sperm motion characteristics and sperm plasma membrane integrity for 9 ejaculates (3 ejaculates per stallion) 
following 24 h of cooled storage (mean ± SEM). 
 
Laboratory 
Parameter§ 
Semen Samples 
2.5/0* 2.5/7.5* 2.5/25* 30* 3:1SD* 3:1/30* 
PMI 77 (4)ab 75 (4)b 70 (5)c 78 (5)a 78 (5)a 78 (5)a 
TMOT 70 (5)c 73 (6)c 69 (4)c 82 (4)ab 83 (4)a 76 (7)b 
PMOT 48 (7)a 39 (7)b 25 (4)c 42 (6)b 42 (5)b 37 (7)b 
VCL 208 (9)c 248 (11)b 281 (13)a 234 (6)b 229 (8)bc 245 (7)b 
VAP 97 (2.5)c 120 (3.2)b 137 (4.8)a 117 (3.3)b 117 (3.9)b 120 (3.9)b 
VSL 63 (3.6)a 66 (3.5)a 63 (4.2)a 68 (4.1)a 69 (3.9)a 66 (5.0)a 
STR 68 (4)a 56 (3)b 46 (3)c 56 (2)b 57 (2)b 55 (3)b 
§ PMI = plasma membranes intact sperm (%) 
 TMOT = total sperm motility (%); PMOT = progressive sperm motility (%); 
 VCL = curvilinear velocity (µm/s); VAP = average-path velocity (µm/s); 
 VSL = straight-line velocity (µm/s); STR = straightness ([VSL/VAP]100; %) 
* 2.5/0 = 2.5 x 106 sperm/mL with 0% seminal plasma added (n = 9) 
 2.5/7.5 = 2.5 x 106 sperm/mL with 7.5% seminal plasma added (n = 9) 
 2.5/25 = 2.5 x 106 sperm/mL with 25% seminal plasma added (n = 9) 
 30 = 30 x 106 sperm/mL (n = 9) 
 3:1SD = 3:1 Simple Dilution (n = 9) 
 3:1/30 = 3:1 Simple Dilution Samples diluted to 30 x 106 sperm/mL with INRA-T with 25% SP (n = 7) 
abc Within rows, rates with different superscripts differed (P < 0.05) 
 
 
 
  
 72 
 
Table 9. Sperm motion characteristics and sperm plasma membrane integrity for 9 ejaculates (3 ejaculates per stallion) 
following 48 h of cooled storage (mean ± SEM). 
 
Laboratory 
Parameter§ 
Semen Samples 
2.5/0* 2.5/7.5* 2.5/25* 30* 3:1SD* 3:1/30* 
PMI 78 (4)ab 75 (4)b 71 (5)c 79 (6)a 80 (4)a 74 (6)b 
TMOT 69 (6)ab 71 (5)a 64 (5)b 75 (5)a 69 (4)ab 63 (6)b 
PMOT 47 (7)a 37 (5)ab 18 (2)d 35 (6)bc 25 (3)cd 24 (6)d 
VCL 197 (13)e 257 (14)b 285 (9)a 242 (11)bc 219 (12)de 230 (12)cd 
VAP 90 (5.2)d 120 (4.3)b 137 (3.4)a 119 (5.6)bc 108 (5.9)c 111 (4.7)bc 
VSL 59 (3.5)b 65 (3.9)ab 56 (2.4)b 68 (5.2)a 58 (3.4)b 59 (4.9)b 
STR 69 (4)a 56 (4)b 41 (1)c 55 (2)b 52 (2)b 53 (3)b 
§ PMI = plasma membranes intact (%) 
 TMOT = total sperm motility (%); PMOT = progressive sperm motility (%); 
 VCL = curvilinear velocity (µm/s); VAP = average-path velocity (µm/s); 
 VSL = straight-line velocity (µm/s); STR = straightness ([VSL/VAP]100; %) 
* 2.5/0 = 2.5 x 106 sperm/mL with 0% seminal plasma added (n = 9) 
 2.5/7.5 = 2.5 x 106 sperm/mL with 7.5% seminal plasma added (n = 9) 
 2.5/25 = 2.5 x 106 sperm/mL with 25% seminal plasma added (n = 9) 
 30 = 30 x 106 sperm/mL (n = 9) 
 3:1SD = 3:1 Simple Dilution (n = 9) 
 3:1/30 = 3:1 Simple Dilution Samples diluted to 30 x 106 sperm/mL with INRA-T with 25% SP (n = 7) 
abc Within rows, rates with different superscripts differed (P < 0.05) 
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At T24 (Table 8), the PMI for 30, 3:1SD, 3:1/30 was higher than 2.5/7.5 and 
2.5/25 (P < 0.05), but similar to 2.5/0 (P ≥ 0.05); and 2.5/7.5 was higher than 2.5/25 (P < 
0.05). The TMOT for 30, 3:1SD, and 3:1/30 was higher than for all of the 2.5 x 106 
treatments (P < 0.05); 3:1SD was higher than 3:1/30 (P < 0.05), but similar to 30 (P ≥ 
0.05). The PMOT for 2.5/0 was higher than all other treatments (P < 0.05), and 2.5/25 
was lower than all other treatments (P < 0.05).The VCL and VAP for 2.5/25 was higher 
than all other treatments (P < 0.05); and 2.5/0 was lower than all other treatments (P < 
0.05) except for the VCL of the 3:1SD treatment (P ≥ 0.05). No difference was seen for 
VSL among all treatments (P ≥ 0.05). The STR for 2.5/0 was higher and for 2.5/25 was 
lower than all other treatments (P < 0.05). 
At T48 (Table 9), the PMI for 30 and 3:1SD was higher than all other treatments 
(P < 0.05), but not different than 2.5/0 (P ≥ 0.05); and 2.5/25 was lower than all other 
treatments (P < 0.05). The TMOT at 2.5/7.5 and 30 was higher than 2.5/25 and 3:1/30 (P 
< 0.05), but was not different than 2.5/0 and 3:1SD (P ≥ 0.05). The PMOT for 2.5/0 was 
higher than all other treatments (P < 0.05) except 2.5/7.5 (P ≥ 0.05); and 2.5/25 and 
3:1/30 were lower than all other treatments (P < 0.05) except 3:1SD (P ≥ 0.05). The 
VCL and VAP for 2.5/25 were higher than all other treatments (P < 0.05). The VSL at 
30 x106 was higher than all other treatments (P < 0.05) except 2.5/7.5 (P ≥ 0.05). The 
STR for 2.5/0 was higher and for 2.5/25 was lower than all other treatments (P < 0.05). 
Values for TMOT at T0 ranged from 71 to 90%. After 48 h of cool-storage, values for 
the 2.5 x 106 sperm/mL treatments declined less than the 30 and 3:1SD treatments. 
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III.3. Discussion  
The “dilution effect” refers to the detrimental effect on sperm quality (typically 
sperm motility) following the addition of a high volume of a diluent to neat semen, 
resulting in a sperm concentration less than 20 x 106 sperm/mL [51-60,65,66,70]. 
Maintenance of sperm quality is important to the success of commercial equine 
artificial insemination programs. Semen dilution with milk-based extenders is a key 
component to maintaining sperm quality especially as storage time increases. In 
stallions, sperm and seminal plasma concentrations typically accepted to optimize sperm 
quality in skim milk-glucose extender are 25 x106 sperm/mL [90] and 5 to 20% seminal 
plasma [75,90]. The optimal sperm concentration is based on a study by Varner et al. 
[70] where the highest total and progressive motility was maintained in semen diluted to 
25 x 106 sperm/mL compared to 50 x 106 and 100 x 106 sperm/mL over 24 h of room-
temperature (25°C) storage. Sperm concentration less than 25 x 106 sperm/mL were not 
evaluated due concerns regarding the “dilution effect” demonstrated in other species [51-
59, 61-69].  
Studies in the stallion evaluating the effect of sperm concentration less than 20 x 
106 sperm/mL on sperm quality have not apparently been previously performed. Some 
low-dose-deep horn insemination studies use, in addition to low sperm numbers in small 
volumes, low sperm concentrations. It is unclear in the Morris et al. study [40] and the 
DHI experiment in Chapter II of this thesis (Experiment 1) whether reduced fertility with 
the 0.5 x 106 insemination dose was due to the low sperm number or low sperm 
concentration (i.e. “dilution effect”). Therefore, it was of interest to compare sperm 
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quality (motility, velocity, and plasma membrane integrity) between conventionally 
diluted semen (i.e. 30 x 106 sperm/mL, 3:1 extender:semen (i.e. 25% seminal plasma)) 
and semen diluted to a very low sperm concentration (the concentration of the sperm 
used for insemination in the 0.5 million sperm group in Experiment 1; i.e. 2.5 x 106 
sperm/mL).  
We found, in contrast to reported finding in other species, that dilution to very 
low concentrations had little effect on sperm quality. Initially at T0, PMI and TMOT for 
conventional semen dilution treatments (30 and 3:1SD) were higher than all 2.5 x 106 
sperm/mL treatments, suggesting that the “dilution effect” may be a factor; however, by 
T48, PMI was similar among the 3:1SD, 30, and 2.5/0 treatments and TMOT was 
similar among the 3:1SD, 30, 2.5/0 and 2.5/7.5 treatments. Notably, at T48, the mean 
PMOT was highest in the 2.5/0 and 2.5/7.5 treatments. These findings suggest that while 
the more dilute samples appear to have slightly lower sperm quality at T0 (e.g. 75-78% 
PMI sperm vs. 81-82% for higher concentrations), the dilute samples maintain PMI, 
TMOT, and PMOT better over time than do more concentrated treatments. The high 
sperm quality in all the 2.5 x 106 sperm/mL samples after 48 h conflicts with the concept 
of the “dilution effect.”  
Historically, the “dilution effect” was studied using electrolyte solutions (e.g., 
sodium chloride, sodium citrate), seminal plasma, or combinations of the two [52-
58,62,63,66,69,73]; however, it was subsequently questioned whether the decrease in 
sperm quality was due to diluent components or was a true “dilution effect” [74]. 
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This study found that component combinations containing BSA, EDTA and/or fructose 
improved sperm longevity; whereas, single component diluents tended to depress 
motility. This difference in single vs. multiple component diluents may explain the 
“dilution effect.” 
Assessment of sperm quality following high dilution has been primarily assessed 
using subjective measures of sperm motility, allowing for bias as sperm density on the 
microscope slide may not only affect the subjective evaluation of motility but will allow 
identification of the dilution treatment. To eliminate this bias, some studies diluted the 
treatments to a uniform concentration prior to analysis [55,57,62,70], whereas other 
studies did not [52,53,56,63,66,69]. Semen samples with higher concentrations could 
have been interpreted to have elevated motility as a result of motile sperm colliding with 
immotile sperm and giving the impression of motility. Makler et al. [73] evaluated 
human sperm motility in semen samples diluted 1:1 to 1:6 (semen volume to diluent 
volume) objectively using multiple exposure photography, and reported no deleterious 
effect of dilution rate on sperm motility. In that study, the neat semen concentrations 
were 12 to 210 x 106 sperm/ml (mean = 73 x 106 sperm/mL) which means that the 
evaluated concentrations were as high as 105 x106 sperm/mL and as low as 1.7 x 106 
sperm/mL. These findings agree with those of the present study and stress the 
importance of objective measures of sperm motility. 
In the 2.5 x 106 sperm/mL treatments, VCL and VAP increased as seminal 
plasma increased. These results are similar to previous studies by Texas workers [77,80] 
that found VCL was higher in 20 vs. 0% seminal plasma when semen was diluted to 25 
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x106 sperm/mL in a skim milk-glucose extender. While they did not evaluate VAP, they 
did report a similar relationship between seminal plasma content and VSL, a finding not 
demonstrated in the present study. It is unclear why the 3:1SD and 3:1/30 samples (also 
with 25% seminal plasma) did not have higher mean VCL and VAP than did the 2.5/7.5 
and 2.5/25 at T24 and T48. It is possible that the relationship between seminal plasma is 
dependent on sperm concentration and that the effect sperm concentration has on pH and 
subsequently velocity. For example, in most species seminal plasma contains ~ 20 mM 
bicarbonate, which may lead to an increase in medium pH and subsequently, sperm 
velocity over time with incubation in air [91]. Higher sperm concentration (30 x 106 vs. 
10 x 106/mL), however, will lower diluent pH and thus may lower sperm velocity [92]. 
In Experiment 1, fertility was less in semen diluted to 2.5 x 106 compared to 5 x 
106 sperm/mL, but this treatment also had the lowest number of sperm in the inseminate 
(0.5 vs. 1 million sperm, respectively). While 2.5 x 106 sperm/mL is more dilute than 5 x 
106 sperm/mL, the latter is still very dilute and resulted in good fertility which suggests 
that, in Experiment 1, fertility differences are due to total sperm number rather than the 
“dilution effect.” 
Previous studies reported that fertility was lower when mares were bred in the 
uterine body with 250 x 106 PMS at concentrations of either 2.5 x 106 sperm/mL in 100 
mL or 5 x 106 PMS/mL in 50 mL compared to 25 x 106 sperm/mL in 10 mL [67,67]. 
Other factors that may have affected the fertility outcome include inseminate volume 
and the possibility of reflux of the semen through the cervix, resulting in a lower number 
of sperm remaining in the uterus. 
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In summary, based on sperm motion characteristics and plasma membrane 
integrity reported in this study, the conception of a “dilution effect” in a stallion at 2.5 x 
106 sperm/mL when diluted with INRA-T is not supported . These findings further 
suggest that there may be other factors such as diluent components, temperature, and 
evaluation method that have led to the concept of the “dilution effect.” 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS* 
 
A comparison of pregnancy rates between hysteroscopic (HYS) and transrectally 
guided deep-horn insemination (TRG) techniques was made using a subthreshold 
insemination dose of 0.5 x 106 total sperm. This subthreshold dose was determined in a 
preliminary experiment using one stallion comparing the fertility of conventional UBI 
with ≥ 1 x 109 sperm (16/18, 89%), 1 x 106 (6/14, 43%), and 0.5 x 106 (3/12, 25%) 
sperm. A subthreshold insemination dose was used to assure that study results would not 
be confounded by supra-threshold levels of sperm that could overcome the effect of 
insemination technique. The results of this study indicate that there was no difference 
detected between the TRG and HYS techniques when a subthreshold insemination dose 
of 0.5 x 106 sperm was inseminated. The TRG technique reduces time factors, 
equipment expense, labor, and risk of possible nosocomial infection. 
The sperm concentration used in Experiment 1 was low (i.e. 2.5 x 106 sperm/mL) 
and there was concern that the “dilution effect” may have affected sperm quality (i.e. 
motility). Experiment 2 (Chapter III experiment) was designed to compare differences in 
sperm extended to 2.5 x 106 sperm/mL to conventional dilution at either 30 x 106 
sperm/mL or 3:1 extender:semen. Initial values for total motility ranged from 71 to 90%;  
_____________________ 
 
*Part of this chapter is reprinted with permission from Hayden SS, Blanchard TL, Brinsko SP, Varner DD, 
Hinrichs K, Love CC. Pregnancy rates in mares inseminated with 0.5 or 1 million sperm using 
hysteroscopic or transrectally guided deep-horn insemination techniques. Theriogenology 2012;78:914-20. 
Copyright 2012 by Elsevier Publishing. 
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and after 48 h of cool-storage, values for the 2.5 x 106 sperm/mL treatments declined  
less than the 30 x 106 sperm/mL and 3:1 extender:semen treatments. These results 
suggest that while total motility for the 2.5 x 106 sperm/mL treatments is initially lower 
than conventional dilution rates, long-term storage (i.e. 48 h) indicates that samples 
diluted to 3:1SD and 30 have a greater rate of decline than the 2.5 x 106 treatments. 
These results suggest that the reduced fertility in the 0.5 million insemination dose (2.5 x 
106 sperm/mL) may be due to the total number of sperm inseminated rather than the low 
sperm concentration. 
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